Document:

Employment Agreement dated January 10, 2005 (Kelly Gray)

  
 Exhibit 10.67

  
 EXECUTION COPY 
  
 EMPLOYMENT AGREEMENT 
  
 This Employment Agreement (“Agreement”), dated January
    , 2005, is by and between St. John Knits, Inc., a California corporation (“Company”), and Kelly Gray, an individual (“Executive”). In consideration of the mutual covenants and agreements set forth
herein, the parties hereto agree as follows. 
  
 ARTICLE I

 EMPLOYMENT 
  
 The Company hereby employs Executive and Executive accepts employment with the Company upon the terms and conditions herein set forth. 
  
 1.1 Employment. Subject to the provisions of Article IV of this
Agreement, the Company hereby employs Executive, and Executive agrees to serve as the Creative Director of the Company and St. John Knits International, Incorporated (“SJKII”) from the period beginning on January 1, 2005 (the
“Effective Date”) and ending December 31, 2007 (the “Term”); provided, however, that commencing with the third anniversary of the Effective Date and on each anniversary thereof (each, an “Extension Date”),
the Term shall be automatically extended for an additional one-year period, unless the Company or Executive provides the other party hereto 90 days prior written notice before the applicable Extension Date that the Term shall not be so extended. In
such position, Executive shall have such duties and authority commensurate with the position of a creative director for a company of similar size and nature and as the Company’s Chief Executive Officer shall otherwise determine from time to
time. Executive agrees to devote substantially her full business time and attention and best efforts to the affairs of SJKII and the Company during the Term, unless this Agreement is terminated sooner in accordance with the provisions hereto.
Executive shall report to the Chief Executive Officer. 
  
 ARTICLE
II 
 COMPENSATION 
  
 2.1 Annual Salary. During the Term, the Company shall pay Executive at the annual rate of: 
  

				
		
	 Year 1:
	  	$	650,000
		
	 Year 2:
	  	$	750,000
		
	 Year 3:
	  	$	750,000

  
 Executive’s
annual base salary, as in effect from time to time, is hereinafter referred to as the “Base Rate”. The Base Rate shall be payable in accordance with the Company’s normal pay periods for exempt employees (bi-weekly). For any extension
period, Executive’s Base Rate shall be determined by the Chief Executive Officer and approved by the Board of Directors. Notwithstanding the above, at no time during the Term of this Agreement shall Executive’s Base Rate be less than that
of the highest paid designer at the Company, other than Marie Gray. 
  

 2.2 Modeling Fee. Executive shall be entitled to a modeling fee for the first year only of this
Agreement. The fee shall be $250,000 and shall be payable in accordance with the Company’s normal pay periods for exempt employees (bi-weekly). 
  
 2.3 Reimbursement of Expenses. During the Term, Executive shall be entitled to receive prompt reimbursement of all reasonable expenses incurred by
Executive in performing services hereunder, including all expenses of travel, entertainment and living expenses while away from home on business at the request of, or in the service of, the Company; provided that such expenses are incurred
and accounted for in accordance with the policies and procedures established by the Company. 
  
 2.4 Annual Bonus. Executive shall be eligible to receive an annual bonus (the “Annual Bonus”) with respect to each year during the Term as follows: Year 1 of up to $200,000 and Years 2 and 3 (or any
extensions of the Term thereafter) of up to 30% of the Base Rate, which shall be determined by, and paid based upon, both (i) performance goals of the Company as established by the Board of Directors of the Company and (ii) performance goals for the
Executive individually, which shall be set by the Chief Executive Officer in consultation with Executive (and approved by the Board of Directors of the Company) within the first 90 days of each year; provided, however, that except as
expressly set forth in this Agreement, to be eligible for any Annual Bonus, Executive must be employed by the Company as of the end of each respective year. 
  
 2.5 Benefits. During the Term, Executive shall be entitled to participate in and be covered by all health, insurance, pension and other employee
plans and benefits currently established for the employees of the Company on at least the same terms as other senior executives of the Company, subject to meeting applicable eligibility requirements. 
  
 2.6 Vacations and Holidays. During Executive’s employment with
the Company, Executive shall be entitled to an annual vacation leave of 4 weeks at full pay, or such greater vacation benefits as may be provided for by the Company’s vacation policies applicable to senior executives. Executive shall be
entitled to such holidays as are established by the Company for all employees. 
  
 2.7 Automobile Allowance. The Company shall pay directly, or reimburse Executive for, all reasonable costs and expenses incurred by Executive in connection with the operation and maintenance of an automobile,
however such amount shall not exceed $2,000 per month. 
  
 2.8
Clothing Allotment. In accordance with the Company’s polices and procedures, Executive shall be entitled to participate in the Company’s clothing allotment program. 
  
 ARTICLE III 
 CONFIDENTIALITY AND NONDISCLOSURE 
  
 3.1
Confidentiality. Executive will not during Executive’s employment by the Company or thereafter at any time disclose, directly or indirectly, to any person or entity or use 

  

 2 

 
for Executive’s own benefit any trade secrets or confidential information relating to the Company’s business operations, marketing data, business
plans, strategies, employees, negotiations and contracts with other companies, or any other subject matter pertaining to the business of the Company or any of its affiliates, clients, customers, consultants, or licensees, known, learned, or acquired
by Executive during the period of Executive’s employment by the Company (unless generally known to the public or to trade sources other than as a result of Executive’s breach of this Article 3.1 or any breach of other confidentiality
obligations by third parties) (collectively “Confidential Information”), except as may be necessary in the ordinary course of performing Executive’s particular duties as an employee of the Company. Except as required by law, prior to
the Effective Date, (a) Executive will not disclose to anyone, other than Executive’s immediate family and legal or financial advisors, the contents of this Agreement and (b) the Company will not disclose to anyone, other than its affiliates
and legal or financial advisors, the contents of this Agreement. 
  
 3.2 Return of Confidential Material. Executive shall promptly deliver to the Company on termination of this Agreement, whether or not for Cause and whatever the reason, or at any time the Company may so request, all memoranda, notes,
records, reports, manuals, drawings, blueprints, Confidential Information and any other documents of a confidential nature belonging to the Company or any of its affiliates, including all copies of such materials which Executive may then possess or
have under Executive’s control. Upon termination of this Agreement, Executive shall not take any document, data, or other material of any nature containing or pertaining to the proprietary information of the Company. 
  
 3.3 Prohibition on Solicitation of Customers. During the term of
Executive’s employment with the Company and for a period of one year thereafter (the “Restricted Period”), Executive shall not, directly or indirectly, either for Executive or for any other person or entity, solicit any person or
entity to terminate such person’s or entity’s contractual and/or business relationship with the Company or any of its affiliates, nor shall Executive interfere with or disrupt or attempt to interfere with or disrupt any such relationship.
None of the foregoing shall be deemed a waiver of any and all rights and remedies the Company may have under applicable law. 
  
 3.4 Prohibition on Solicitation of Employees, Agents or Independent Contractors. During the Restricted Period, Executive will not solicit any of
the employees, agents, or independent contractors of the Company or any of its affiliates to leave the employ of the Company or any of its affiliates for a competitive company or business. However, Executive may solicit any employee, agent or
independent contractor who voluntarily terminates his or her employment with the Company or any of its affiliates after a period of 120 days have elapsed since the termination date of such employee, agent or independent contractor. None of the
foregoing shall be deemed a waiver of any and all rights and remedies the Company may have under applicable law. 
  
 3.5 Right to Injunctive and Equitable Relief. Executive’s obligations not to disclose or use Confidential Information and to refrain from the
solicitations described in this Article III are of a special and unique character which gives them a peculiar value. The Company cannot be reasonably or adequately compensated for damages in an action at law in the event Executive breaches such
obligations. Therefore, Executive expressly agrees that the 

  

 3 

 
Company shall be entitled to injunctive and other equitable relief without bond or other security in the event of such breach in addition to any other rights
or remedies which the Company may possess or be entitled to pursue. Furthermore, the obligations of Executive and the rights and remedies of the Company under this Article III are cumulative and in addition to, and not in lieu of, any obligations,
rights, or remedies created by applicable law relating to misappropriation or theft of trade secrets or Confidential Information. 
  
 3.6 Survival of Obligations. Executive agrees that the terms of this Article III shall survive the Term and the termination of Executive’s
employment with the Company. 
  
 ARTICLE IV 
 TERMINATION 
  
 4.1 Definitions. For purposes of this Article IV, the following definitions shall apply to the terms set forth below: 
  
 (a) Cause. “Cause” shall include the following: 

 
 (i) Executive’s conviction of, or plea of guilty or
nolo contendere to, (A) a felony under the laws of the United States or any state thereof or (B) any other crime (excluding a petty misdemeanor) involving theft, fraud, dishonesty or moral turpitude; 
  
 (ii) Executive engages in willful misconduct that results in
any material harm to the Company; 
  
 (iii)
Executive’s willful failure to substantially carry out Executive’s duties (except where such failure is a result of Executive’s death or Disability) within 10 days after a written demand for substantial performance approved by a
resolution of the Board of Directors is delivered to Executive by the Board of Directors that specifically identifies the manner in which the Board of Directors believes Executive has not substantially performed Executive’s duties; 

 
 (iv) a material breach of this Agreement by Executive and
Executive fails to cure such breach within 30 days following written notice delivered by the Company; or 
  
 (v) Executive’s material violation of any written Company policy and Executive fails to cure such violation within 10 days following
written notice delivered by the Company; provided, however, that a repeat violation of the same or similar policy shall not be subject to a cure period. 
  
 For purposes of this Article 4.1(a), no act, or failure to act, on the part of Executive shall be considered
“willful” to the extent such act, or failure to act, is based upon a directive given pursuant to a resolution duly adopted by the Board of Directors. 
  

 4 

 (b) Good Reason. “Good Reason” shall mean, without Executive’s prior written
consent: 
  
 (i) the assignment to Executive of
duties inconsistent with the position and status of Executive as set forth in this Agreement; 
  
 (ii) a substantial alteration or diminution in the nature, status or prestige of Executive’s responsibilities or a diminution in
Executive’s title or reporting level from that set forth in this Agreement; provided, however, that after a Change in Control (as defined hereinafter), a change in Executive’s title or reporting level shall not be deemed Good Reason so
long as Executive maintains substantially the same duties as Executive had prior to the Change in Control; 
  
 (iii) the relocation of the Company’s executive offices or principal business location to a point more than 50 miles from the
location of such offices or business as of the date of this Agreement; 
  
 (iv) a reduction by the Company of (A) Executive’s Base Rate, or (B) Executive’s Annual Bonus opportunity as described in Article 2.4; 
  
 (v) a failure by the Company to obtain from any successor, before the succession takes place, an agreement
to assume and perform this Agreement; or 
  
 (vi)
a material breach of this Agreement by the Company. 
  
 provided that any
event described in clauses (i) through (vi) above shall constitute Good Reason only if the Company fails to cure such event within 20 days after receipt from Executive of written notice of the event which constitutes Good Reason; provided,
further, that Good Reason shall cease to exist for an event on the 180th day following the later of its occurrence or Executive’s actual knowledge thereof, unless Executive has given the Company written notice thereof prior to such date.
For purposes of clause (ii) above, a “Change in Control” shall be deemed to mean when Vestar Capital Partners, and the partners therein and the respective affiliates thereof, hold, in the aggregate, less than 50% of the stock of SJKII.

  
 (c) Disability. “Disability” shall mean a
physical or mental incapacity as a result of which Executive becomes unable to substantially perform her duties hereunder (reasonable absences because of sickness for up to four consecutive months excepted; provided, however, that any
new period of incapacity or absences shall be deemed to be part of a prior period of incapacity or absences if the prior period terminated within 90 days of the beginning of the new period of incapacity or absence and the incapacity or absence is
determined by the Board of Directors, in good faith, to be related to the prior incapacity or absence). A determination of Disability shall be subject to the certification of a qualified medical doctor agreed to by the Company and Executive or in
the event of Executive’s incapacity to designate a doctor, Executive’s legal representative. In the absence of agreement between the Company and Executive, each party shall nominate a qualified medical doctor and the two doctors so
nominated shall select a third doctor, who shall make the determination as to Disability. 
  

 5 

 4.2 Termination by Company. The Company may terminate Executive’s employment hereunder
immediately for Cause. Subject to the other provisions contained in this Agreement, the Company may terminate this Agreement for any reason other than Cause upon 30 days’ written notice to Executive. The effective date of termination (the
“Termination Date”) shall be considered to be 30 days subsequent to written notice of termination; however, the Company may elect to have Executive leave the Company immediately. 
  
 4.3 Termination by Executive. Executive may terminate her employment
hereunder upon 30 days’ written notice to the Company. The Termination Date shall be considered to be 30 days subsequent to written notice of termination; however, the Company may elect to have Executive leave the Company immediately.

  
 4.4 Death or Disability of Executive. Executive’s
employment hereunder shall terminate immediately upon the death or Disability of Executive. In such event, the Termination Date shall be the date of death or the date of the determination of Executive’s Disability in accordance with the
provisions of Article 4.1(c), as applicable. 
  
 4.5 Severance
Benefits Received Upon Termination. 
  
 (a) Termination by
the Company for Cause or by Executive Without Good Reason. If Executive’s employment is terminated by the Company for Cause or by Executive other than for Good Reason, then Executive shall be entitled to (i) the Base Rate through the
Termination Date, (ii) any Annual Bonus earned but unpaid as of the Termination Date for any previously completed year, (iii) reimbursement for any unreimbursed business expenses properly incurred by Executive in accordance with Company policy prior
to the Termination Date, (iv) credit for any vacation earned but not taken, and (v) such employee benefits, if any, to which Executive may be entitled under the employee benefit plans of the Company (the amounts described in clauses (i) through (v)
hereof being referred to as the “Accrued Rights”). The Company shall thereafter have no further obligations to Executive under this Agreement. 
  
 (b) Termination Due to Death or Disability. If Executive’s employment is terminated due to Executive’s death or Disability, then
Executive shall be entitled to the Accrued Rights. The Company shall thereafter have no further obligations to Executive under this Agreement. 
  
 (c) Termination by the Company Without Cause or by Executive for Good Reason. If Executive’s employment is terminated by the Company without
Cause or by Executive for Good Reason, then, subject to Executive’s continued compliance with the provisions of Article III and entering into a general release agreement with the Company, Executive shall be entitled to: 
  
 (i) continued payment of the Base Rate for a period of 18
months following the Termination Date (the “Severance Period”), payable in equal monthly installments; 
  
 (ii) a lump sum payment, within 60 days following the beginning of the year subsequent to the year in which the Termination Date occurs,
equal to the product of (A) the Annual Bonus that Executive would have actually earned in the year in 

  

 6 

 
which the Termination Date occurs (if Executive had remained employed by the Company and based upon achievement of the performance goals established for such
year), multiplied by (B) a fraction, the numerator of which is the number of days that Executive was employed during the year in which the Termination Date occurs and the denominator of which is 365; 
  
 (iii) during the Severance Period, continuation of health
insurance coverage as then in effect for Executive pursuant to Executives continuing coverage rights under COBRA; 
  
 (iv) if such termination occurs during calendar year 2005, then Executive shall be entitled to any remaining amounts under the modeling
fee set forth in Section 2.2 that have not yet been paid; and 
  
 (v) the Accrued Rights. 
  
 (d)
Expiration of the Agreement. If the Company should give Executive notice, pursuant to Section 1.1, that it does not intend to renew this Agreement beyond the Agreement’s expiration date (the “Expiration Date”), then, subject to
Executive remaining employed through the Expiration Date and entering into a general release agreement with the Company, Executive shall be entitled to: 
  
 (i) continued payment of the Base Rate (in effect as of the Expiration Date) for a period of 9 months following the Expiration Date (the
“Severance Period”), payable in equal monthly installments; 
  
 (ii) a lump sum payment, within 60 days following the beginning of the year subsequent to the year in which the Expiration Date occurs, equal to the product of (A) the Annual Bonus that Executive would have actually
earned in the year in which the Expiration Date occurs (if Executive had remained employed by the Company and based upon achievement of the performance goals established for such year), multiplied by (B) a fraction, the numerator of which is the
number of days that Executive was employed during the year in which the Expiration Date occurs and the denominator of which is 365 (i.e. Executive shall not receive credit towards a bonus for performance goals that are met after the Expiration
Date); 
  
 (iii) during the Severance Period,
continuation of health insurance coverage as then in effect for Executive pursuant to Executives continuing coverage rights under COBRA; and 
  
 (iv) the Accrued Rights. 
  
 ARTICLE V 
 GENERAL PROVISIONS 
  
 5.1 Notice. For purposes of this Agreement, notices and all other
communications provided for in this Agreement shall be in writing and shall be deemed to have been duly given when delivered by hand with written acknowledgment of receipt, or when 

  

 7 

 
received by the addressee, if mailed by United States registered mail, return receipt requested, postage prepaid, or when received by the addressee, if sent
by a national recognized overnight delivery service as follows: 
  

			
	 If to the Company:
	  	St. John Knits, Inc.
	 	  	17622 Armstrong Avenue
	 	  	Irvine, California 92614
	 	  	Attn: CEO
		
	 If to Executive:
	  	Kelly Gray
	 	  	c/o St. John Knits, Inc.
	 	  	17622 Armstrong Avenue
	 	  	Irvine, California 92614

  
 or such other address as either party
may have furnished to the other in writing in accordance herewith, except that notices of change of address shall be effective only upon receipt. 
  
 5.2 No Waivers. No provision of this Agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in
writing signed by Executive and the Company. No waiver by either party hereto at any time of any breach by the other party hereto of, or compliance with, any condition or provision of this Agreement to be performed by such other party shall be
deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. 
  
 5.3 Beneficial Interests. This Agreement shall inure to the benefit of and be enforceable by Executive’s personal and legal representatives,
executors, administrators, successors, heirs, distributees, devisees and legatees. If Executive should die while any amounts are still payable to her hereunder, all such amounts, unless otherwise provided herein, shall be paid in accordance with the
terms of this Agreement to Executive’s devisee, legatee, or other designee or, if there be no such designee, to Executive’s estate. 
  
 5.4 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of California, without regard to
conflicts of laws principles thereof. 
  
 5.5 Severability or
Partial Invalidity. The invalidity or unenforceability of any provisions of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect. 
  
 5.6 Counterparts. This Agreement may be executed in one or more
counterparts, each of which shall be deemed to be an original but all of which together will constitute one and the same instrument. 
  
 5.7 Legal Fees and Expenses. Should any party institute any action or proceeding to enforce this Agreement or any provision hereof, or for damages
by reason of any alleged breach of this Agreement or of any provision hereof, or for a declaration of rights hereunder, the prevailing party in any such action or proceeding shall be entitled to receive from 

  

 8 

 
the other party all costs and expenses, including reasonable attorneys’ fees, incurred by the prevailing party in connection with such action or
proceeding. 
  
 5.8 Entire Agreement. This Agreement
constitutes the entire agreement of the parties and supersedes all prior written or oral and all contemporaneous oral agreements, understandings, and negotiations between the parties with respect to the subject matter hereof. This Agreement is
intended by the parties as the final expression of their agreement with respect to such terms as are included in this Agreement and may not be contradicted by evidence of any prior or contemporaneous agreement. The parties further intend that this
Agreement constitutes the complete and exclusive statement of its terms and that no extrinsic evidence may be introduced in any judicial proceeding involving this Agreement. 
  
 5.9 Assignment. This Agreement and the rights, duties, and obligations hereunder may not be assigned or delegated by
any party without the prior written consent of the other party and any attempted assignment or delegation without such prior written consent shall be void and be of no effect. Notwithstanding the foregoing provisions of this Section 5.9, the Company
may assign or delegate its rights, duties, and obligations hereunder to any of its affiliates or to any person or entity which succeeds to all or substantially all of the business of the Company through merger, consolidation, reorganization, or
other business combination or by acquisition of all or substantially all of the assets of the Company. 
  
 5.10 Set-Off. The Company’s obligation to pay Executive the amounts provided hereunder shall be subject to set-off, counterclaim or recoupment
of any amounts loaned or advanced by the Company or any of its affiliates to Executive. 
  
 5.11 Indemnity. Upon Executives request, the Company and Executive shall enter into an indemnification agreement consistent to indemnification agreement entered into between the Company and other officers and
directors of the Company. 
  
 5.12 Representations.

  
 (a) Executive hereby represents to the Company that the
execution and delivery of this Agreement by Executive and the Company and the performance by Executive of her duties hereunder shall not constitute a breach of, or otherwise contravene, the terms of any employment agreement or other agreement or
policy to which Executive is a party or otherwise bound. 
  
 (b)
The Company hereby represents to Executive that (i) the Company is fully authorized and empowered by action of the Board of Directors to enter into this Agreement and (ii) the performance of the Company’s obligations under this Agreement will
not violate any agreement between the Company and any other person, firm or organization. 
  
 5.13 Withholding. The Company may withhold from any amounts payable under this Agreement such Federal, state and local taxes as may be required to be withheld pursuant to any applicable law or regulation.

  
 5.14 Arbitration. Except as provided in Article 3.5 of
this Agreement, any controversy arising out of or relating to Executive’s employment, this Agreement, its 

  

 9 

 
enforcement or interpretation, or because of an alleged breach, default, or misrepresentation in connection with any of its provisions, shall be resolved by
arbitration before the American Arbitration Association in Orange County, California. Final resolution of any dispute through arbitration may include any remedy or relief which the arbitrator deems just and equitable. Any award or relief granted by
the arbitrator hereunder shall be final and binding on the parties hereto and may be enforced by any court of competent jurisdiction. The parties agree that they are hereby waiving any rights to trial by jury in any action, proceeding or
counterclaim brought by either of the parties against the other in connection with any matter whatsoever arising out of or in any way connected with this Agreement or Executive’s employment. 
  
 5.15 Survival. The respective rights and obligations of the parties to
this Agreement shall survive any termination of Executive’s employment to the extent necessary to the intended preservation of such rights and obligations. 
  

5.16 No Mitigation. Except as expressly provided in this Agreement, the Company agrees that any income and other employment benefits received by
Executive from any and all sources other than the Company or any of its affiliates before, during or after the Term shall in no way reduce or otherwise affect the Company’s obligation to make payments and afford benefits to Executive as
provided in this Agreement. 
  
 IN WITNESS WHEREOF, the parties
have executed this Agreement as of the date first above written. 
  

			
	 St. John Knits, Inc.,
 a California corporation

		
	 By: 
	 	 
	 	 	 Name: Richard Cohen

	
	 
	 Kelly Gray

  

 10Securities Purchase Agreement

 Exhibit 10.74 
  
 SECURITIES PURCHASE 
  
 AGREEMENT 
  
 Dated as of January 26, 2005 
  
 among 
  
 PATH 1 NETWORK
TECHNOLOGIES INC. 
  
 and 
  
 THE PURCHASERS LISTED ON EXHIBIT A 

 Table of Contents 
  

							
	 	 	 	 	 	  	Page

	ARTICLE I Purchase and Sale of Preferred Stock and Warrants	  	1
				
	 	 	Section 1.1	 	 Purchase and Sale of Preferred Stock and Warrants.
	  	1
				
	 	 	Section 1.2	 	 Closings.
	  	1
				
	 	 	Section 1.3	 	 Warrants.
	  	2
				
	 	 	Section 1.4	 	 Conversion Shares and Warrant Shares.
	  	2
		
	ARTICLE II Representations and Warranties	  	2
				
	 	 	Section 2.1	 	 Representations and Warranties of the Company.
	  	2
				
	 	 	Section 2.2	 	 Representations and Warranties of the Purchasers
	  	13
		
	ARTICLE III Covenants	  	15
				
	 	 	Section 3.1	 	 Disclosure of Transactions and Other Material Information.
	  	15
				
	 	 	Section 3.2	 	 Registration and Listing.
	  	15
				
	 	 	Section 3.3	 	 Inspection Rights.
	  	16
				
	 	 	Section 3.4	 	 Compliance with Laws.
	  	16
				
	 	 	Section 3.5	 	 Keeping of Records and Books of Account.
	  	16
				
	 	 	Section 3.6	 	 Other Agreements.
	  	16
				
	 	 	Section 3.7	 	 Preemptive Rights.
	  	16
				
	 	 	Section 3.8	 	 Reservation of Shares.
	  	18
				
	 	 	Section 3.9	 	 Non-public Information.
	  	18
				
	 	 	Section 3.10	 	 [Reserved].
	  	19
				
	 	 	Section 3.11	 	 Beneficial Ownership Restrictions.
	  	19
		
	ARTICLE IV Conditions	  	19
				
	 	 	Section 4.1	 	 Conditions Precedent to the Obligation of the Company to Close and to Sell the Shares and Warrants on the First Closing
Date.
	  	19
				
	 	 	Section 4.2	 	 Conditions Precedent to the Obligation of the Purchasers to Close and to Purchase the Shares and Warrants on the First Closing
Date.
	  	20
				
	 	 	Section 4.3	 	 Conditions Precedent to the Obligation of the Company to Close and to Sell the Shares and Warrants on the Second Closing
Date
	  	22

  

 i 

 Table of Contents 
 (continued) 
  

							
	 	 	 	  	 	  	Page

	 	 	Section 4.4	  	 Conditions Precedent to the Obligations of the Purchasers to Close and to Purchase the Shares and Warrants on the Second Closing
Date.
	  	22
		
	ARTICLE V Certificate Legend	  	24
				
	 	 	Section 5.1	  	 Legend.
	  	24
		
	ARTICLE VI Termination	  	25
				
	 	 	Section 6.1	  	 Termination by Mutual Consent.
	  	25
				
	 	 	Section 6.2	  	 Effect of Termination.
	  	25
		
	ARTICLE VII Indemnification	  	25
				
	 	 	Section 7.1	  	 General Indemnity.
	  	25
				
	 	 	Section 7.2	  	 Indemnification Procedure.
	  	26
		
	 ARTICLE VIII Miscellaneous
	  	27
				
	 	 	Section 8.1	  	 Fees and Expenses.
	  	27
				
	 	 	Section 8.2	  	 Specific Enforcement; Consent to Jurisdiction.
	  	27
				
	 	 	Section 8.3	  	 Entire Agreement; Amendment.
	  	27
				
	 	 	Section 8.4	  	 Notices.
	  	28
				
	 	 	Section 8.5	  	 Waivers.
	  	28
				
	 	 	Section 8.6	  	 Headings.
	  	29
				
	 	 	Section 8.7	  	 Successors and Assigns.
	  	29
				
	 	 	Section 8.8	  	 No Third Party Beneficiaries.
	  	29
				
	 	 	Section 8.9	  	 Governing Law.
	  	29
				
	 	 	Section 8.10	  	 Survival.
	  	29
				
	 	 	Section 8.11	  	 Counterparts.
	  	29
				
	 	 	Section 8.12	  	 Severability.
	  	29
				
	 	 	Section 8.13	  	 Further Assurances.
	  	30
				
	 	 	Section 8.14	  	 Independent Nature of Purchasers’ Obligations and Rights.
	  	30

  

 ii 

 SECURITIES PURCHASE AGREEMENT 
  
 This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of January 26, 2005, by and among Path 1
Network Technologies Inc., a Delaware corporation (the “Company”), and the entities listed on Exhibit A hereto (each, a “Purchaser” and collectively, the “Purchasers”), for the purchase and
sale by the Purchasers of shares of the Company’s 7% Convertible Preferred Stock, par value $0.001 per share (the “Preferred Stock”), and warrants to purchase shares of the Company’s common stock, par value $0.001 per
share (the “Common Stock”). 
  
 The parties
hereto agree as follows: 
  
 ARTICLE I 
  
 Purchase and Sale of Preferred Stock and Warrants 
  
 Section 1.1 Purchase and Sale of Preferred Stock and Warrants. Upon
the following terms and conditions, the Company shall issue and sell to the Purchasers, and each Purchaser shall, severally but not jointly, purchase from the Company, shares of Preferred Stock (the “Shares”) and warrants to
purchase shares of Common Stock (the “Warrants”), in each case, as set forth opposite each such Purchaser’s name on Exhibit A hereto, for an aggregate purchase price to the Company from all Purchasers of $2,808,750 (the
“Purchase Price”), as follows: (a) at the First Closing on the First Closing Date (as both terms are defined in Section 1.2(a)), 556,538 Shares, and that number of Warrants as described in Section 1.3, for an aggregate purchase
price of $1,808,750; and (b) at the Second Closing on the Second Closing Date (as both terms are defined in Section 1.2(b)), 307,691 Shares, and that number of Warrants as described in Section 1.3, for an aggregate purchase price of $1,000,000. The
Company and the Purchasers are executing and delivering this Agreement in accordance with and in reliance upon the exemption from securities registration afforded by Section 4(2) of the U.S. Securities Act of 1933, as amended, and the rules and
regulations promulgated thereunder (the “Securities Act”), including Regulation D (“Regulation D”), and/or upon such other exemption from the registration requirements of the Securities Act as may be available with
respect to any or all of the investments to be made hereunder. 
  
 Section 1.2 Closings. First Closing. The closing of the sale to and purchase by each Purchaser of the Shares and Warrants contemplated by Section 1.1(a) (the “First Closing”) shall take place at the offices of
the Company located at 6215 Ferris Square, Suite 140, San Diego, California 92121 at noon, Pacific Time (i) on or before January 27, 2005, provided, that all of the conditions set forth in Sections 4.1 and 4.2 hereof shall have been fulfilled
or waived in accordance herewith, or (ii) at such other time and place or on such date as the Purchasers and the Company may agree upon (the “First Closing Date”). At the First Closing, the Company shall deliver to each Purchaser
certificates evidencing the Shares and Warrants being purchased by it on the First Closing Date which shall be registered in such Purchaser’s name as stated on Exhibit A hereto, against delivery to the Company of payment by certified
check or wire transfer in an amount equal to that amount set forth opposite such Purchaser’s name on Exhibit A hereto under the heading “Dollar Amount of Investment at First Closing”. 

 (b) Second Closing. The closing of the sale to and purchase by each Purchaser of the Shares and
Warrants contemplated by Section 1.1(b) (the “Second Closing” and together with the First Closing, the “Closings”) shall take place at the offices of the Company located at 6215 Ferris Square, Suite 140, San Diego,
California 92121 at 10:00 a.m., Pacific Time, (i) on February 18, 2005, or (ii) at such other time and place or on such date as the Purchasers and the Company may agree upon (the “Second Closing Date”). At the Second Closing, the
Company shall deliver to each Purchaser certificates evidencing the Shares and Warrants being purchased by it on the Second Closing Date which shall be registered in such Purchaser’s name as stated on Exhibit A hereto, against delivery
to the Company of payment by certified check or wire transfer in an amount equal to that amount set forth opposite such Purchaser’s name on Exhibit A hereto under the heading “Dollar Amount of Investment at Second Closing”. For
purposes of this Agreement, a “Business Day” means any day except Saturday, Sunday and any day which is a legal holiday or a day on which banking institutions in the State of California generally are authorized or required by law or
other government actions to close. 
  
 Section 1.3
Warrants. At the First Closing, the Company shall issue to the Purchasers Warrants to purchase an aggregate of 278,268 shares of Common Stock, in substantially the form attached hereto as Exhibit B. Such Warrants shall be exercisable
for five (5) years from the First Closing Date and shall have an initial exercise price equal to $4.20 per share. At the Second Closing, the Company shall issue to the Purchasers Warrants to purchase an aggregate of 153,847 shares of Common Stock,
in substantially the form attached hereto as Exhibit B. Such Warrants shall be exercisable for five (5) years from the First Closing Date and shall have an initial exercise price equal to $4.20 per share. 
  
 Section 1.4 Conversion Shares and Warrant Shares. The Company has
authorized and has reserved and covenants to continue to reserve, free of preemptive rights and other similar contractual rights of stockholders, a number of its authorized but unissued shares of Common Stock equal to the aggregate number of shares
of Common Stock necessary to effect the conversion of all the Shares and the exercise of all the Warrants. Any shares of Common Stock issuable upon conversion of the Shares (and such shares when issued) are herein referred to as the
“Conversion Shares”. Any shares of Common Stock issuable upon exercise of the Warrants (and such shares when issued) are herein referred to as the “Warrant Shares”. The Shares, the Conversion Shares, the Warrants,
the Warrant Shares and the PIK Dividend Shares (as defined in the Registration Rights Agreement) are sometimes collectively referred to herein as the “Securities”. 
  
 ARTICLE II 
  
 Representations and Warranties 
  
 Section 2.1 Representations and Warranties of the Company. In order to induce the Purchasers to enter into this Agreement and to purchase the
Shares and Warrants, the Company hereby makes the following representations and warranties to the Purchasers, subject in each case to any exceptions identified in the Schedule of Exceptions attached hereto: 
  
 (a) Organization, Good Standing and Power. The Company is a
corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware 

  

 2 

 
and has the requisite corporate power to own, lease and operate its properties and assets and to conduct its business as it is now being conducted. The
Company does not have any Subsidiaries (as defined in Section 2.1(g)) or own securities of any kind in any other entity, except as disclosed in the Commission Documents (as defined in Section 2.1(f)). The Company and each such Subsidiary is duly
qualified as a foreign corporation to do business and is in good standing in every jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except for any jurisdiction(s) (alone or in the
aggregate) in which the failure to be so qualified will not have a Material Adverse Effect. For the purposes of this Agreement, “Material Adverse Effect” means any adverse effect on the business, operations, properties, prospects or
financial condition of the Company or its Subsidiaries and which is material to such entity or other entities controlling or controlled by such entity or which is likely to materially hinder the performance by the Company of its obligations
hereunder and under the other Transaction Documents (as defined in Section 2.1(b) hereof). 
  
 (b) Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and perform this Agreement, the Certificate of Designations establishing the Shares in the form of
Exhibit D attached hereto (the “Certificate of Designations”), the Registration Rights Agreement in the form of Exhibit E attached hereto (the “Registration Rights Agreement”), the Warrants, and all
other agreements and documents contemplated hereby and thereby and executed by the Company or to which the Company is party (collectively, the “Transaction Documents”), and to issue and sell the Shares and the Warrants in accordance
with the terms hereof. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by it of the transactions contemplated thereby have been duly and validly authorized by all necessary corporate action,
and, except as contemplated by Section 3.10, no further consent or authorization of the Company, its Board of Directors or its stockholders is required. This Agreement has been duly executed and delivered by the Company. The other Transaction
Documents will have been duly executed and delivered by the Company at the First Closing or the Second Closing, as the case may be. Each of the Transaction Documents constitutes, or shall constitute when executed and delivered, a valid and binding
obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, reorganization, moratorium, liquidation, conservatorship, receivership or similar laws
relating to, or affecting generally the enforcement of, creditor’s rights and remedies or by other equitable principles of general application. 
  
 (c) Capitalization. The authorized capital stock of the Company and the shares thereof currently issued and outstanding as of December 31, 2004,
are set forth on Schedule 2.1(c) hereto. All of the outstanding shares of the Company’s Common Stock and any other security of the Company have been duly and validly authorized. Except as disclosed in the Commission Documents or as set
forth on Schedule 2.1(c) hereto, no shares of Common Stock or any other security of the Company are entitled to preemptive rights or registration rights and there are no outstanding options, warrants, scrip, rights to subscribe to, call or
commitments of any character whatsoever relating to, or securities or rights convertible into, any shares of capital stock of the Company. Furthermore, except as disclosed in the Commission Documents or as set forth on Schedule 2.1(c) hereto,
there are no contracts, commitments, understandings, or arrangements by which the Company is or may become bound to issue additional shares of the capital stock of the Company or options, securities or rights convertible into shares of capital

  

 3 

 
stock of the Company. Except for customary transfer restrictions contained in agreements entered into by the Company in order to sell restricted securities,
the Company is not a party to or bound by any agreement or understanding granting registration or anti-dilution rights to any individual, corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or political subdivision thereof) or other entity of any kind (a “Person”) with respect to any of its equity or debt securities. The Company is not a party to, and it has no
knowledge of, any agreement or understanding restricting the voting or transfer of any shares of the capital stock of the Company. The offer and sale of all capital stock, convertible securities, rights, warrants, or options of the Company issued
prior to the First Closing complied with all applicable federal and state securities laws, and no holder of such securities has a right of rescission or claim for damages with respect thereto which could have a Material Adverse Effect. The Company
has furnished or made available to the Purchasers true and correct copies of the Company’s Certificate of Incorporation as in effect on the date hereof (the “Certificate”), and the Company’s Bylaws as in effect on the date
hereof (the “Bylaws”). 
  
 (d) Issuance of
Securities. The Shares and the Warrants to be issued at each Closing have been duly authorized by all necessary corporate action and, when paid for or issued in accordance with the terms hereof, the Shares shall be validly issued and
outstanding, fully paid and nonassessable and free and clear of all liens, encumbrances and rights of refusal of any kind and the holders shall be entitled to all rights accorded to a holder of Preferred Stock. When the Conversion Shares are issued
and paid for in accordance with the terms of the Preferred Stock, such shares will be duly authorized by all necessary corporate action and validly issued and outstanding, fully paid and nonassessable, free and clear of all liens, encumbrances and
rights of refusal of any kind and the holders shall be entitled to all rights accorded to a holder of Common Stock. When the Warrant Shares are issued and paid for in accordance with the terms of the Warrants, such shares will be duly authorized by
all necessary corporate action and validly issued and outstanding, fully paid and nonassessable, free and clear of all liens, encumbrances and rights of refusal of any kind and the holders shall be entitled to all rights accorded to a holder of
Common Stock. When the PIK Dividend Shares are issued in accordance with the terms of the Certificate of Designations, such shares will be duly authorized by all necessary corporate action and validly issued and outstanding, fully paid and
nonassessable, free and clear of all liens, encumbrances and rights of refusal of any kind and the holders shall be entitled to all rights accorded to a holder of Common Stock. 
  
 (e) No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the
consummation by the Company of the transactions contemplated hereby and thereby do not and will not (i) violate any provision of the Certificate or Bylaws or any Subsidiary’s comparable charter documents, (ii) conflict with, or constitute a
default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, mortgage, deed of trust, indenture, note, bond,
license, lease agreement, instrument or obligation to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries’ respective properties or assets are bound, (iii) create or impose a lien,
mortgage, security interest, charge or encumbrance of any nature on any property or asset of the Company or any of its Subsidiaries under any agreement or any commitment to which the Company or any of its Subsidiaries is a party or by which the
Company or any of its Subsidiaries 

  

 4 

 
is bound or by which any of their respective properties or assets are bound, or (iv) result in a violation of any federal, state, local or foreign statute,
rule, regulation, order, judgment or decree (including federal and state securities laws and regulations) applicable to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or
affected, except, in all cases other than violations pursuant to clauses (i) or (iv) (with respect to federal and state securities laws) above, for such conflicts, defaults, terminations, amendments, acceleration, cancellations and violations as
would not, individually or in the aggregate, have a Material Adverse Effect. The business of the Company and its Subsidiaries is not being conducted in violation of any laws, ordinances or regulations of any governmental entity, except for possible
violations which singularly or in the aggregate do not and will not have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is required under federal, state, foreign or local law, rule or regulation to obtain any consent,
authorization or order of, or make any filing or registration with, any court or governmental agency in order for it to execute, deliver or perform any of its obligations under the Transaction Documents or issue and sell the Securities in accordance
with the terms hereof or thereof (other than any filings which may be required to be made by the Company with the Securities and Exchange Commission (the “Commission”), the American Stock Exchange prior to or subsequent to each
Closing, or state securities administrators subsequent to each Closing, or any registration statement which may be filed pursuant hereto or thereto). 
  
 (f) Commission Documents; Financial Statements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of
1934, as amended (the “Exchange Act”), and the Company has timely filed all reports, schedules, forms, statements and other documents required to be filed by it with the Commission pursuant to the reporting requirements of the
Exchange Act, including material filed pursuant to Section 13(a) or 15(d) of the Exchange Act (all of the foregoing, including filings incorporated by reference therein, being referred to herein as the “Commission Documents”). The
Company has delivered or made available (through the SEC EDGAR website) to the Purchasers true and complete copies of the Commission Documents filed with the Commission since December 31, 2000. The Company has not provided to the Purchasers any
material non-public information or other information which, according to applicable law, rule or regulation, should have been disclosed publicly by the Company but which has not been so disclosed, other than with respect to the transactions
contemplated by this Agreement. At the time of its filing, the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2004 (the “Form 10-Q”) complied in all material respects with the requirements of
the Exchange Act and the rules and regulations of the Commission promulgated thereunder and other federal, state and local laws, rules and regulations applicable to such documents, and the Form 10-Q did not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. At the time of its filing, the Company’s Annual
Report on Form 10-K/A for the fiscal year ended December 31, 2003 (the “Form 10-K”) complied in all material respects with the requirements of the Exchange Act and the rules and regulations of the Commission promulgated thereunder
and other federal, state and local laws, rules and regulations applicable to such documents, and, at the time of its filing, the Form 10-K did not contain any untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. As of their respective dates (taking into account all restatements thereof in subsequent Commission Documents),
the financial statements of the Company included in the Commission Documents complied as to form in all material respects with applicable accounting requirements and the published rules and regulations of the Commission or other applicable rules and
regulations with respect thereto. Such financial statements (taking into account all 
  

 5 

 
restatements thereof in subsequent Commission Documents) have been prepared in accordance with generally accepted accounting principles
(“GAAP”) applied on a consistent basis during the periods involved (except (i) as may be otherwise indicated in such financial statements or the Notes thereto or (ii) in the case of unaudited interim statements, to the extent they
may not include footnotes or may be condensed or summary statements), and fairly present in all material respects the financial position of the Company and its Subsidiaries as of the dates thereof and the results of operations and cash flows for the
periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments). 
  
 (g) Subsidiaries. Schedule 2.1(g) hereto sets forth each Subsidiary of the Company, showing the jurisdiction of its incorporation or
organization and showing the percentage of each Person’s ownership of the outstanding stock or other interests of such Subsidiary. For the purposes of this Agreement, “Subsidiary” shall mean any Person of which at least a
majority of the securities or other ownership interest having ordinary voting power (absolutely or contingently) for the election of directors or other Persons performing similar functions are at the time owned directly or indirectly by the Company
and/or any of its other Subsidiaries. All of the outstanding shares of capital stock of each Subsidiary have been duly authorized and validly issued, and are fully paid and nonassessable. There are no outstanding preemptive, conversion or other
rights, options, warrants or agreements granted or issued by or binding upon any Subsidiary for the purchase or acquisition of any shares of capital stock of any Subsidiary or any other securities convertible into, exchangeable for or evidencing the
rights to subscribe for any shares of such capital stock. Neither the Company nor any Subsidiary is subject to any obligation (contingent or otherwise) to repurchase or otherwise acquire or retire any shares of the capital stock of any Subsidiary or
any convertible securities, rights, warrants or options of the type described in the preceding sentence. Neither the Company nor any Subsidiary is party to, nor has any knowledge of, any agreement restricting the voting or transfer of any shares of
the capital stock of any Subsidiary. 
  
 (h) No Material
Adverse Change. Since September 30, 2004, the Company has not experienced or suffered any Material Adverse Effect. 
  
 (i) No Undisclosed Liabilities. Neither the Company nor any of its Subsidiaries has any liabilities, obligations, claims or losses (whether
liquidated or unliquidated, secured or unsecured, absolute, accrued, contingent or otherwise) other than those set forth on the balance sheet included in the Form 10-Q or incurred in the ordinary course of the Company’s or its Subsidiaries
respective businesses since September 30, 2004, and which, individually or in the aggregate, do not or would not have a Material Adverse Effect on the Company or its Subsidiaries. 
  
 (j) No Undisclosed Events or Circumstances. Since September 30, 2004, no event or circumstance has occurred or exists
with respect to the Company or its Subsidiaries or their respective businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but
which has not been so publicly announced or disclosed. 
  

 6 

 (k) Indebtedness. Schedule 2.1(k) hereto sets forth as of the date hereof all outstanding
secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For purposes of this Agreement: (x) “Indebtedness” of any Person means, without duplication (A) any
indebtedness for borrowed money in excess of $100,000, (B) any obligations issued, undertaken or assumed as the deferred purchase price of property or services (other than trade payables entered into in the ordinary course of business) in excess of
$100,000, (C) all reimbursement or payment obligations with respect to letters of credit, surety bonds and other similar instruments, (D) any obligations evidenced by notes, bonds, debentures or similar instruments, including obligations so
evidenced incurred in connection with the acquisition of property, assets or businesses, (E) any indebtedness in excess of $100,000 created or arising under any conditional sale or other title retention agreement, or incurred as financing, in either
case with respect to any property or assets acquired with the proceeds of such indebtedness (even though the rights and remedies of the seller or bank under such agreement in the event of default are limited to repossession or sale of such
property), (F) all monetary obligations under any leasing or similar arrangement which, in connection with GAAP, consistently applied for the periods covered thereby, is classified as a capital lease with a present value in excess of $100,000, (G)
all indebtedness referred to in clauses (A) through (F) above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any mortgage, lien, pledge, charge, security interest or other
encumbrance upon or in any property or assets (including accounts and contract rights) owned by any Person, even though the Person which owns such assets or property has not assumed or become liable for the payment of such indebtedness, and (H) all
Contingent Obligations in respect of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G) above; and (y) “Contingent Obligation” means, as to any Person, any direct or indirect liability,
contingent or otherwise, of that Person with respect to any indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such liability, or the primary effect thereof, is to provide
assurance to the obligee of such liability that such liability will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability will be protected (in whole or in part) against loss with
respect thereto in excess of $100,000 due under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness. 
  
 (l) Title to Assets. Each of the Company and the Subsidiaries has good
and valid title to all of its real and personal property, free and clear of any mortgages, pledges, charges, liens, security interests or other encumbrances of any nature whatsoever, except as disclosed in the Commission Documents or such that,
individually or in the aggregate, do not have a Material Adverse Effect. All leases to real and personal property of the Company and each of its Subsidiaries are valid and subsisting and in full force and effect. 
  
 (m) Actions Pending. There is no action, suit, claim, investigation,
arbitration, alternate dispute resolution proceeding or other proceeding pending or, to the knowledge of the Company, threatened against the Company or any Subsidiary which questions the validity of this Agreement or any of the other Transaction
Documents or any of the transactions contemplated 

  

 7 

 
hereby or thereby or any action taken or to be taken pursuant hereto or thereto. There is no action, suit, claim, investigation, arbitration, alternate
dispute resolution proceeding or other proceeding pending or, to the knowledge of the Company, threatened against or involving the Company, any Subsidiary or any of their respective properties or assets, which individually or in the aggregate, would
have a Material Adverse Effect. There are no outstanding orders, judgments, injunctions, awards or decrees of any court, arbitrator or governmental or regulatory body against the Company or any Subsidiary or any officers or directors of the Company
or any Subsidiary in their capacities as such, which individually, or in the aggregate, would have a Material Adverse Effect. 
  
 (n) Compliance with Law. The business of the Company and the Subsidiaries has been and is presently being conducted in accordance with all
applicable federal, state and local governmental laws, rules, regulations and ordinances, except as set forth in the Commission Documents or such that, individually or in the aggregate, the noncompliance therewith would not have a Material Adverse
Effect. The Company and each of its Subsidiaries have all franchises, permits, licenses, consents and other governmental or regulatory authorizations and approvals necessary for the conduct of its business as now being conducted by it unless the
failure to possess such franchises, permits, licenses, consents and other governmental or regulatory authorizations and approvals, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect. 
  
 (o) Taxes. The Company and each of the Subsidiaries has accurately
prepared and filed all federal, state and other tax returns required by law to be filed by it, has paid or made provisions for the payment of all taxes shown to be due and all additional assessments, and adequate provisions have been and are
reflected in the financial statements of the Company and the Subsidiaries for all current taxes and other charges to which the Company or any Subsidiary is subject and which are not currently due and payable. None of the federal income tax returns
of the Company or any Subsidiary have been audited by the Internal Revenue Service. The Company has no knowledge of any additional assessments, adjustments or contingent tax liability (whether federal or state) of any nature whatsoever, whether
pending or threatened against the Company or any Subsidiary for any period, nor of any basis for any such assessment, adjustment or contingency. 
  
 (p) Certain Fees. Except for Silverwood Partners LLC, the Company has not employed any broker or finder or incurred any liability for any brokerage
or investment banking fees, commissions, finders’ structuring fees, financial advisory fees or other similar fees in connection with the Transaction Documents. 
  
 (q) Disclosure. To the best of the Company’s knowledge, neither this Agreement or the Schedules hereto nor any
other documents, certificates or instruments furnished to the Purchaser by or on behalf of the Company or any Subsidiary in connection with the transactions contemplated by this Agreement contain any untrue statement of a material fact or omit to
state a material fact necessary in order to make the statements made herein or therein, in the light of the circumstances under which they were made herein or therein, not misleading. 
  
 (r) Intellectual Property. The Company and each of the Subsidiaries owns or possesses valid licenses under all the
Proprietary Rights owned by it and have no knowledge that 

  

 8 

 
such rights are in conflict with the rights of others. As of the date of this Agreement, neither the Company nor any of its Subsidiaries has received any
written notice that any Proprietary Rights have been declared unenforceable or otherwise invalid by any court or governmental agency. As of the date of this Agreement, there is, to the knowledge of the Company, no material existing infringement,
misuse or misappropriation of any Proprietary Rights by others. From September 30, 2004 to the date of this Agreement, neither the Company nor any of its Subsidiaries has received any written notice alleging that the operation of the business of the
Company or any of its Subsidiaries infringes in any material respect upon the intellectual property rights of others. “Proprietary Rights” shall mean patents, trademarks, domain names (whether or not registered) and any patentable
improvements or copyrightable derivative works thereof, websites and intellectual property rights relating thereto, service marks, trade names, copyrights, licenses and authorizations, and all rights with respect to the foregoing. 
  
 (s) Environmental Compliance. The Company and each of its Subsidiaries
have obtained all material approvals, authorization, certificates, consents, licenses, orders and permits or other similar authorizations of all governmental authorities, or from any other Person, that are required under any Environmental Laws, the
absence of which would have a Material Adverse Effect. “Environmental Laws” shall mean all applicable laws relating to the protection of the environment including, without limitation, all requirements pertaining to reporting,
licensing, permitting, controlling, investigating or remediating emissions, discharges, releases or threatened releases of hazardous substances, chemical substances, pollutants, contaminants or toxic substances, materials or wastes, whether solid,
liquid or gaseous in nature, into the air, surface water, groundwater or land, or relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of hazardous substances, chemical substances,
pollutants, contaminants or toxic substances, material or wastes, whether solid, liquid or gaseous in nature. The Company has all necessary governmental approvals required under all Environmental Laws and used in its business or in the business of
any of its Subsidiaries, except for such instances as would not individually or in the aggregate have a Material Adverse Effect. The Company and each of its Subsidiaries are also in compliance with all other limitations, restrictions, conditions,
standards, requirements, schedules and timetables required or imposed under all Environmental Laws. Except for such instances as would not individually or in the aggregate have a Material Adverse Effect, there are no past or present events,
conditions, circumstances, incidents, actions or omissions relating to or in any way affecting the Company or its Subsidiaries that violate or may violate any Environmental Law after the First Closing or that may give rise to any Environmental
Liabilities, or otherwise form the basis of any claim, action, demand, suit, proceeding, hearing, study or investigation (i) under any Environmental Law, or (ii) based on or related to the manufacture, processing, distribution, use, treatment,
storage (including, without limitation, underground storage tanks), disposal, transport or handling, or the emission, discharge, release or threatened release of any hazardous substance. “Environmental Liabilities” means all
liabilities of a Person (whether such liabilities are owed by such Person to governmental authorities, third parties or otherwise) whether currently in existence or arising hereafter which arise under or relate to any Environmental Law. 

 
 (t) Books and Records; Internal Accounting Controls. The books,
records and documents of the Company and its Subsidiaries accurately reflect in all material respects the information relating to the business of the Company and the Subsidiaries, the location and collection of their assets, and the nature of all
transactions giving rise to the obligations or 

  

 9 

 
accounts receivable of the Company or any Subsidiary. The Company and each of its Subsidiaries maintain a system of internal accounting controls sufficient,
in the judgment of the Company’s Board of Directors, to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to
permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate actions are taken with respect to any differences. 
  
 (u) Material Agreements. Except for the Transaction Documents or those that are included as exhibits to the Commission Documents, neither the
Company nor any Subsidiary is a party to any written or oral contract, instrument, agreement, commitment, obligation, plan or arrangement, a copy of which would be required to be filed with the Commission (collectively, “Material
Agreements”) if the Company or any Subsidiary were registering securities under the Securities Act. The Company and each of its Subsidiaries has in all material respects performed all the obligations required to be performed by them to date
under the foregoing agreements, have received no notice of default and, to the best of the Company’s knowledge, are not in default under any Material Agreement now in effect, the result of which could cause a Material Adverse Effect. No written
or oral contract, instrument, agreement, commitment, obligation, plan or arrangement of the Company or of any Subsidiary limits or shall limit the payment of dividends on its Common Stock. 
  
 (v) Transactions with Affiliates. Except as disclosed in the
Commission Documents, there are no loans, leases, agreements, contracts, royalty agreements, management contracts or arrangements or other continuing transactions between (a) the Company, any Subsidiary or any of their respective customers or
suppliers, on the one hand, and (b) on the other hand, any officer, employee, consultant or director of the Company, or any of its Subsidiaries, or any Person owning 5% or more of the capital stock of the Company or any Subsidiary or any member of
the immediate family of such Person, officer, employee, consultant, director or 5% or greater stockholder or any corporation or other entity controlled by such officer, employee, consultant, director or stockholder. 
  
 (w) Securities Act of 1933. The Company has complied and will comply
with all applicable federal and state securities laws in connection with the offer, issuance and sale of the Securities hereunder. Neither the Company nor anyone acting on its behalf, directly or indirectly, has or will sell, offer to sell or
solicit offers to buy any of the Securities, or similar securities to, or solicit offers with respect thereto from, or enter into any preliminary conversations or negotiations relating thereto with, any Person, or has taken or will take any action
so as to bring the issuance and sale of any of the Securities under the registration provisions of the Securities Act and applicable state securities laws. Neither the Company nor any of its affiliates, nor any Person acting on its or their behalf,
has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection with the offer or sale of any of the Securities. 
  
 (x) Governmental Approvals. Except for the filing of any notice prior
or subsequent to each Closing that may be required under applicable state and/or federal securities 

  

 10 

 
laws (which if required, shall be filed on a timely basis), no authorization, consent, approval, license, exemption of, filing or registration with any court
or governmental department, commission, board, bureau, agency or instrumentality, domestic or foreign, is or will be necessary for, or in connection with, the execution or delivery of the Shares and the Warrants, or for the performance by the
Company of its obligations under the Transaction Documents. 
  
 (y) Employees. Neither the Company nor any Subsidiary has any collective bargaining arrangements or agreements covering any of its employees. Except as set forth in the Commission Documents, neither the Company nor any Subsidiary has
any employment contract, agreement regarding proprietary information, non-competition agreement, non-solicitation agreement, confidentiality agreement, or any other similar contract or restrictive covenant, relating to the right of any officer,
employee or consultant to be employed or engaged by the Company or such Subsidiary, which contract or agreement is required to be disclosed in the Commission Documents but which is not so disclosed. Since September 30, 2004, no officer, consultant
or key employee of the Company or any Subsidiary whose termination, either individually or in the aggregate, could have a Material Adverse Effect, has terminated or, to the knowledge of the Company, has any present intention of terminating his or
her employment or engagement with the Company or any Subsidiary. 
  
 (z) Absence of Certain Developments. Except as set forth in the Commission Documents, since September 30, 2004, neither the Company nor any Subsidiary has: 
  
 (i) issued any stock, bonds or other corporate securities or any rights, options or warrants with respect thereto other
than under the Company’s stock option/stock issuance plans; 
  
 (ii) borrowed any amount or incurred or become subject to any liabilities (absolute or contingent) except current liabilities incurred in the ordinary course of business which are comparable in nature and amount to the current liabilities
incurred in the ordinary course of business during the comparable portion of its prior fiscal year, as adjusted to reflect the current nature and volume of the Company’s or such Subsidiary’s business; 
  
 (iii) discharged or satisfied any lien or encumbrance or paid any obligation
or liability (absolute or contingent), other than current liabilities paid in the ordinary course of business; 
  
 (iv) declared or made any payment or distribution of cash or other property to stockholders with respect to its stock, or purchased or redeemed, or made
any agreements so to purchase or redeem, any shares of its capital stock; 
  
 (v) sold, assigned or transferred any other tangible assets, or canceled any debts or claims, except in the ordinary course of business; 
  
 (vi) sold, assigned or transferred any patent rights, trademarks, trade names, copyrights, trade secrets or other
intangible assets or intellectual property rights, or disclosed any proprietary confidential information to any Person except in the ordinary course of business or to the Purchasers or their representatives; 
  

 11 

 (vii) suffered any substantial losses or waived any rights of material value, whether or not in the
ordinary course of business, or suffered the loss of any material amount of prospective business; 
  
 (viii) made any changes in employee compensation except in the ordinary course of business and consistent with past practices; 
  
 (ix) made capital expenditures or commitments therefor that aggregate in
excess of $100,000; 
  
 (x) entered into any other transaction
other than in the ordinary course of business, or entered into any other material transaction, whether or not in the ordinary course of business; 
  
 (xi) made charitable contributions or pledges in excess of $25,000; 
  
 (xii) suffered any material damage, destruction or casualty loss, whether or not covered by insurance; 
  
 (xiii) experienced any material problems with labor or management in
connection with the terms and conditions of their employment; 
  
 (xiv) effected any two or more events of the foregoing kind which in the aggregate would cause a Material Adverse Effect; or 
  
 (xv) entered into an agreement, written or otherwise, to take any of the foregoing actions. 
  
 (aa) Use of Proceeds. The proceeds from the sale of the Shares and the Warrants shall be used by the Company for
working capital purposes only, and shall not be used to repay any outstanding Indebtedness or any loans to any officer, director, affiliate or insider of the Company. 
  
 (bb) Public Utility Holding Company Act and Investment Company Act Status. The Company is not a “holding
company” or a “public utility company” as such terms are defined in the Public Utility Holding Company Act of 1935, as amended. The Company is not, and as a result of and immediately upon each Closing will not be, an “investment
company” or a company “controlled” by an “investment company”, within the meaning of the Investment Company Act of 1940, as amended. 
  
 (cc) ERISA. No liability to the Pension Benefit Guaranty Corporation has been incurred with respect to any Plan by the Company or any of its
Subsidiaries which is or would cause a Material Adverse Effect. The execution and delivery of this Agreement and the issue and sale of the Shares and the Warrants will not involve any transaction which is subject to the prohibitions of Section 406
of ERISA or in connection with which a tax could be imposed pursuant to Section 4975 of the Internal Revenue Code of 1986, as amended (the “Code”); provided that, if any Purchaser, or any Person that owns a beneficial interest in
any Purchaser, is an “employee pension benefit plan” (within the meaning of Section 3(2) of ERISA) with respect 

  

 12 

 
to which the Company is a “party in interest” (within the meaning of Section 3(14) of ERISA), the requirements of Sections 407(d)(5) and 408(e) of
ERISA, if applicable, are met. As used in this Section 2.1(cc), the term “Plan” shall mean an “employee pension benefit plan” (as defined in Section 3 of ERISA) which is or has been established or maintained, or to which
contributions are or have been made, by the Company or any Subsidiary or by any trade or business, whether or not incorporated, which, together with the Company or any Subsidiary, is under common control, as described in Section 414(b) or (c) of the
Code. 
  
 (dd) Delisting Notification. The Company has not
received a delisting notification from the American Stock Exchange, and, to its knowledge, there are no existing facts or circumstances that could give rise to the delisting of the Common Stock from the American Stock Exchange. 
  
 (ee) Sarbanes-Oxley. The Company is in compliance with any and all
applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective and applicable to it as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date
hereof, except where such noncompliance would not have, individually or in the aggregate, a Material Adverse Effect. 
  
 Section 2.2 Representations and Warranties of the Purchasers. Each of the Purchasers hereby makes the following representations and warranties to
the Company with respect solely to itself and not with respect to any other Purchaser: 
  
 (a) Organization and Standing of the Purchasers. If such Purchaser is an entity, such Purchaser is a corporation, limited liability company or partnership duly incorporated or organized, validly existing and in
good standing under the laws of the jurisdiction of its incorporation or organization. 
  
 (b) Authorization and Power. Such Purchaser has the requisite power and authority to enter into and perform the Transaction Documents and to purchase the Shares and Warrants being sold to it hereunder. The
execution, delivery and performance of the Transaction Documents by such Purchaser and the consummation by it of the transactions contemplated hereby have been duly authorized by all necessary corporate, limited liability company or partnership
action, and no further consent or authorization of such Purchaser or its Board of Directors, stockholders, members, managers or partners, as the case may be, is required. This Agreement has been duly executed and delivered by such Purchaser. Each of
the Transaction Documents constitute, or shall constitute when executed and delivered, valid and binding obligations of such Purchaser enforceable against such Purchaser in accordance with their terms, except as such enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, conservatorship, receivership or similar laws relating to, or affecting generally the enforcement of, creditor’s rights and remedies or by other equitable principles of
general application. 
  
 (c) Acquisition for Investment.
Such Purchaser is purchasing the Shares and acquiring the Warrants (and would acquire the underlying Common Stock) solely for its own account for the purpose of investment and not with a view to or for sale in connection with the distribution
thereof. Such Purchaser does not have a present intention to sell any of the 

  

 13 

 
Securities, nor a present arrangement (whether or not legally binding) or intention to effect any distribution of any of the Securities to or through any
Person; provided, however, that by making the representations herein and subject to Section 2.2(e) below, such Purchaser does not agree to hold any of the Securities for any minimum or other specific term and reserves the right to
pledge any of the Securities for margin purposes and/or to dispose of any of the Securities at any time in accordance with federal and state securities laws applicable to such disposition. Such Purchaser acknowledges that it (i) has such knowledge
and experience in financial and business matters such that such Purchaser is capable of evaluating the merits and risks of its investment in the Company, (ii) is able to bear the financial risks associated with an investment in the Securities, and
(iii) has been given full access to such records of the Company and the Subsidiaries and to the officers of the Company and the Subsidiaries as it has deemed necessary or appropriate to conduct its due diligence investigation. 
  
 (d) Rule 144. Such Purchaser understands that the Securities must be
held indefinitely unless such Securities are registered under the Securities Act or an exemption from registration is available. Such Purchaser acknowledges that it is familiar with Rule 144 of the rules and regulations of the Commission, as
amended, promulgated pursuant to the Securities Act (“Rule 144”), and that such Purchaser has been advised that Rule 144 permits resales only under certain circumstances. Such Purchaser understands that to the extent that Rule 144
is not available, such Purchaser will be unable to sell any Securities without either registration under the Securities Act or the existence of another exemption from such registration requirement. Such Purchaser will not, prior to the effectiveness
of the Registration Statement (as defined in the Registration Rights Agreement), if then prohibited by law or regulation, sell, offer to sell, solicit offers to buy, dispose of, loan, pledge or grant any right with respect to the Securities. Without
limiting the generality of the foregoing, such Purchaser will not, prior to the effectiveness of the Registration Statement, sell any of the Securities short “against the box”. 
  
 (e) General. Such Purchaser understands that the Securities are being offered and sold in reliance on a transactional
exemption from the registration requirements of federal and state securities laws and the Company is relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings of such Purchaser set forth
herein in order to determine the applicability of such exemptions and the suitability of such Purchaser to acquire the Securities. Such Purchaser understands that no United States federal or state agency or any government or governmental agency has
passed upon or made any recommendation or endorsement of the Securities. 
  
 (f) Opportunities for Additional Information. Such Purchaser acknowledges that such Purchaser has had the opportunity to ask questions of and receive answers from, or obtain additional information from, the
executive officers of the Company concerning the financial and other affairs of the Company, and to the extent deemed necessary in light of such Purchaser’s personal knowledge of the Company’s affairs, such Purchaser has asked such
questions and received answers to the full satisfaction of such Purchaser, and such Purchaser desires to invest in the Company. 
  
 (g) No General Solicitation. Such Purchaser acknowledges that the Securities were not offered to such Purchaser by means of any form of general or
public solicitation or general advertising, or publicly disseminated advertisements or sales literature, including (i) any 

  

 14 

 
advertisement, article, notice or other communication published in any newspaper, magazine, or similar media, or broadcast over television or radio, or (ii)
any seminar or meeting to which such Purchaser was invited by any of the foregoing means of communications. 
  
 (h) Accredited Investor. Such Purchaser is an accredited investor (as defined in Rule 501 of Regulation D), and such Purchaser has such experience
in business and financial matters that it is capable of evaluating the merits and risks of an investment in the Securities. Such Purchaser acknowledges that an investment in the Securities is speculative and involves a high degree of risk.

  
 ARTICLE III 
  
 Covenants 
  
 The Company covenants with each Purchaser as follows, which covenants are for
the benefit of each Purchaser and its respective permitted assignees (and, where expressly so indicated, the respective Purchasers severally and not jointly covenant with and for the benefit of the Company as follows). 
  
 Section 3.1 Disclosure of Transactions and Other Material Information.
On or before 8:30 a.m., New York City time, on the second Business Day immediately following the First Closing Date, the Company shall file a Current Report on Form 8-K with the Commission describing the terms of the transactions contemplated by the
Transaction Documents and including as exhibits to such Current Report on Form 8-K this Agreement, the Warrants, the Certificate of Designations and the Registration Rights Agreement in the form required by the Exchange Act (including all
attachments, the “8-K Filing”). From and after the filing of the 8-K Filing with the Commission, no Purchaser shall be in possession of any material, nonpublic information received from the Company, any of its Subsidiaries or any of
their respective officers, directors, employees or agents that is not disclosed in the 8-K Filing. The Company shall not, and shall cause each of its Subsidiaries and its and each of their respective officers, directors, employees and agents not to,
provide any Purchaser with any material, nonpublic information regarding the Company or any of its Subsidiaries from and after the filing of the 8-K Filing with the Commission without the express written consent of such Purchaser. Neither the
Company nor any Purchaser shall issue any press releases or any other public statements with respect to the transactions contemplated hereby; provided, however, that the Company shall be entitled, without the prior approval of any
Purchaser, to make any press release or other public disclosure with respect to such transactions (i) in substantial conformity with the 8-K Filing and contemporaneously therewith, and (ii) as is required by applicable law and regulations, including
the applicable rules and regulations of the American Stock Exchange (provided that in the case of clause (i) above, the Purchasers shall be consulted by the Company (although the consent of the Purchasers shall not be required) in connection with
any such press release or other public disclosure prior to its release). 
  
 Section 3.2 Registration and Listing. The Company will cause its Common Stock to continue to be registered under Section 12(b) or 12(g) of the Exchange Act, will comply in all respects with its reporting and
filing obligations under the Exchange Act, will comply with all requirements related to any registration statement filed pursuant to the Registration Rights 

  

 15 

 
Agreement, and will not take any action or file any document (whether or not permitted by the Securities Act or the rules promulgated thereunder) to
terminate or suspend such registration or to terminate or suspend its reporting and filing obligations under the Exchange Act or Securities Act, except as permitted herein. The Company shall use its best efforts to continue the listing or trading of
its Common Stock on The American Stock Exchange or any successor (or equivalent, or better) market. The Company will promptly file the “Listing Application” for, or in connection with, the issuance and delivery of the Conversion Shares,
the Warrant Shares and the PIK Dividend Shares on The American Stock Exchange. 
  
 Section 3.3 Inspection Rights. In the event the Registration Statement is not effective or has been suspended, the Company shall permit, during normal business hours and upon reasonable request and reasonable
notice, each Purchaser or any employees, agents or representatives thereof, so long as such Purchaser shall be obligated hereunder to purchase the Shares or shall beneficially own the Shares or Conversion Shares, or shall own Warrant Shares or the
Warrants which, in the aggregate, represent more than two percent (2%) of the total combined voting power of all Company voting securities then outstanding, to (subject to an appropriate non-disclosure agreement) examine and make reasonable copies
of and extracts from the records and books of account of, and visit and inspect, during the term of the Warrants, the properties, assets, operations and business of the Company and any Subsidiary, and to discuss the affairs, finances and accounts of
the Company and any Subsidiary with any of its officers, consultants, directors, and key employees. 
  
 Section 3.4 Compliance with Laws. The Company shall comply, and cause each Subsidiary to comply, with all applicable laws, rules, regulations and
orders, the noncompliance with which could have a Material Adverse Effect. 
  
 Section 3.5 Keeping of Records and Books of Account. The Company shall keep and cause each Subsidiary to keep adequate records and books of account, in which complete entries will be made in accordance with
GAAP consistently applied, reflecting all financial transactions of the Company and its Subsidiaries, and in which, for each fiscal year, all proper reserves for depreciation, depletion, obsolescence, amortization, taxes, bad debts and other
purposes in connection with its business shall be made. 
  
 Section 3.6 Other Agreements. The Company shall not enter into any agreement in which the terms of such agreement would restrict or impair the right or ability of the Company or any Subsidiary to perform under any Transaction
Document. 
  
 Section 3.7 Preemptive Rights. 
  
 (a) Until the first anniversary of the Closing Date, the Company hereby
grants to each Purchaser (but not its assigns) that (A) still owns Shares or Conversion Shares immediately prior to the issuance of the “New Securities” (as defined in Section 3.7(b)), (B) purchased Shares on the Closing Date, and (C) was
not an officer or director of the Company as of the Closing Date (any such Purchaser, for such purpose, an “Eligible Purchaser”), a right (the “Preemptive Right”) to purchase all or any part of such Eligible
Purchaser’s pro rata share of any New Securities that the Company may, from time to time, propose to sell and issue. The pro rata share for each Eligible Purchaser, for purposes of the Preemptive Right, is the ratio of (x) the number of shares
of Common Stock then held or deemed to be held by such Eligible Purchaser immediately prior to the issuance of the New Securities 
  

 16 

 
(assuming the full conversion of the Shares and the full exercise of the Warrants), to (y) the total number of shares of Common Stock of the Company
outstanding immediately prior to the issuance of the New Securities (after giving effect to the full conversion of the Shares and the full exercise of the Warrants).  
  
 (b) For purposes of this Section 3.7, “New Securities” shall mean any Common Stock or Preferred Stock,
whether or not authorized on the date hereof, and rights, options or warrants to purchase Common Stock or Preferred Stock and securities of any type whatsoever that are, or may become, convertible into Common Stock or Preferred Stock;
provided, however, that “New Securities” does not include the following: 
  
 (i) shares of capital stock of the Company issued or issuable upon conversion or exercise of any currently outstanding securities or any New Securities
issued in accordance with this Agreement (including the Conversion Shares and the Warrant Shares); 
  
 (ii) shares or options or warrants for Common Stock granted to officers, directors and employees of, and consultants to, the Company pursuant to stock
option or purchase plans or other compensatory agreements approved by the Board of Directors; 
  
 (iii) shares of Common Stock or Preferred Stock issued in connection with any pro rata stock split, stock dividend (including PIK Dividend Shares) or recapitalization by the Company; 
  
 (iv) shares of capital stock, or options or warrants to purchase capital
stock, issued to a strategic investor in connection with a strategic commercial agreement as determined by the Board of Directors; 
  
 (v) shares of capital stock, or options or warrants to purchase capital stock, issued pursuant to commercial borrowing, secured lending or lease
financing transaction approved by the Board of Directors; 
  
 (vi) shares of capital stock, or options or warrants to purchase capital stock, issued pursuant to the acquisition of another corporation or entity by the Company by consolidation, merger, purchase of all or substantially all of the assets,
or other reorganization in which the Company acquires, in a single transaction or series of related transactions, all or substantially all of the assets of such other corporation or entity or fifty percent (50%) or more of the voting power of such
other corporation or entity or fifty percent (50%) or more of the equity ownership of such other corporation or entity; 
  
 (vii) shares of capital stock issued in an underwritten public securities offering pursuant to a registration statement filed under the Securities Act;

  
 (viii) shares of capital stock, or options or warrants to
purchase capital stock, issued to current or prospective customers or suppliers of the Company approved by the Board of Directors as compensation or accommodation in lieu of other payment, compensation or accommodation to such customer or supplier;

  

 17 

 (ix) shares of capital stock, or warrants to purchase capital stock, issued to any Person that provides
services to the Company as compensation therefor pursuant to an agreement approved by the Board of Directors; 
  
 (x) shares of capital stock, or options or warrants to purchase capital stock, offered in a transaction where purchase of such securities by any
Purchaser would cause such transaction to fail to comply with applicable federal or state securities laws or would cause an applicable registration or qualification exemption to fail to be available to the Company; provided, however,
that this clause (x) shall apply only to the Purchaser or Purchasers who would cause any such failure, and not to any of the other Purchasers; and 
  
 (xi) securities issuable upon conversion or exercise of the securities set forth in paragraphs (i) – (x) above. 
  
 (c) In the event that the Company proposes to undertake an issuance of New
Securities, it shall give each Eligible Purchaser written notice (the “Notice”) of its intention, describing the type of New Securities, the price, and the general terms upon which the Company proposes to issue the same. Each
Eligible Purchaser shall have the lesser of (i) ten (10) Business Days, or (ii) the maximum amount of time that any other prospective third-party investor to which the Company proposes to issue such New Securities is given to determine whether such
third-party investor wishes to participate in the purchase of such New Securities (such lesser time period, the “Determination Period”), after receipt of such Notice to agree to purchase all or any portion of its pro rata share of
such New Securities at the price and upon the terms specified in the Notice by giving written notice to the Company and stating therein the quantity of New Securities to be purchased. In the event that any New Securities subject to the Preemptive
Right are not purchased by the Eligible Purchaser within the Determination Period, the Company shall have ninety (90) days thereafter to sell (or enter into an agreement pursuant to which the sale of New Securities that had been subject to the
Preemptive Right shall be closed, if at all, within sixty (60) days from the date of said agreement) the New Securities with respect to which the rights of the Purchaser were not exercised at a price and upon terms, including manner of payment, no
more favorable to the purchasers thereof than specified in the Notice. In the event the Company has not sold all offered New Securities within such ninety (90) day period (or sold and issued New Securities in accordance with the foregoing within
sixty (60) days from the date of such agreement), the Company shall not thereafter issue or sell any New Securities, without first complying again with the procedures set forth in this Section 3.7. 
  
 Section 3.8 Reservation of Shares. So long as the Shares or Warrants
remain outstanding, the Company shall take all action necessary to at all times have authorized, and reserved for the purpose of issuance, the maximum number of shares of Common Stock to effect the conversion of the Shares and the exercise of the
Warrants. 
  
 Section 3.9 Non-public Information. Neither
the Company nor any of its officers or agents shall disclose any material non-public information about the Company to any Purchaser, and no Purchaser or any of its affiliates, officers or agents will solicit any material non-public information from
the Company. 
  

 18 

 Section 3.10 [Reserved]. Beneficial Ownership Restrictions. 
  
 (a) Notwithstanding anything to the contrary set forth in this Agreement or
any other Transaction Document (including, without limitation, the Warrants and the Certificate of Designations), at no time may a Purchaser convert or exercise a Security if the number of shares of Common Stock to be issued pursuant to such
conversion or exercise, when aggregated with all other shares of Common Stock owned by such Purchaser at such time, would result in such Purchaser beneficially owning (as determined in accordance with Section 13(d) of the Exchange Act, and the rules
thereunder) in excess of 4.99% of the then issued and outstanding shares of Common Stock outstanding at such time; provided, however, that upon a Purchaser providing the Company with sixty-one (61) days notice (the “Waiver
Notice”) that such Purchaser would like to waive this Section 3.11(a) with regard to any or all shares of Common Stock issuable upon conversion or exercise of any Security, this Section 3.11(a) shall be of no force or effect with regard to
those Securities referenced in the Waiver Notice; provided, further, that any Purchaser may waive this Section 3.11(a) by so indicating on the signature page to this Agreement, any such waiver to be effective on and as of the date of
this Agreement. 
  
 (b) Notwithstanding anything to the contrary
set forth in this Agreement or any other Transaction Document (including, without limitation, the Warrants and the Certificate of Designations), at no time may a Purchaser convert or exercise a Security if the number of shares of Common Stock to be
issued pursuant to such conversion or exercise, when aggregated with all other shares of Common Stock owned by such Purchaser at such time, would result in such Purchaser beneficially owning (as determined in accordance with Section 13(d) of the
Exchange Act, and the rules thereunder) in excess of 9.99% of the then issued and outstanding shares of Common Stock outstanding at such time; provided, however, that upon a Purchaser providing the Company with a Waiver Notice that
such Purchaser would like to waive this Section 3.11(b) with regard to any or all shares of Common Stock issuable upon conversion or exercise of a Security, this Section 3.11(b) shall be of no force or effect with regard to those Securities
referenced in the Waiver Notice. 
  
 ARTICLE IV 

 
 Conditions 
  
 Section 4.1 Conditions Precedent to the Obligation of the Company to Close
and to Sell the Shares and Warrants on the First Closing Date. The obligation hereunder of the Company to close and issue and sell the Shares and the Warrants to the Purchasers on the First Closing Date is subject to the satisfaction or waiver,
at or before the First Closing, of the conditions set forth below. These conditions are for the Company’s sole benefit and may be waived by the Company at any time in its sole discretion. 
  
 (a) Accuracy of the Purchasers’ Representations and Warranties.
The representations and warranties of each Purchaser shall be true and correct in all material respects as of the date when made and as of the First Closing Date as though made at that time, except for representations and warranties that are
expressly made as of a particular date, which shall be true and correct in all material respects as of such date. 
  

 19 

 (b) Performance by the Purchasers. Each Purchaser shall have performed, satisfied and complied in
all material respects with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by such Purchaser at or prior to the First Closing Date. 
  
 (c) No Injunction. No statute, rule, regulation, executive order,
decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation of any of the transactions contemplated by this Agreement.

  
 (d) Delivery of Purchase Price. The Purchase Price for
the Shares and Warrants being purchased at the First Closing shall have been delivered to the Company at the First Closing. 
  
 (e) Delivery of Transaction Documents. The Transaction Documents to which the Purchasers are party shall have been duly executed and delivered by
the Purchasers to the Company. 
  
 Section 4.2 Conditions
Precedent to the Obligation of the Purchasers to Close and to Purchase the Shares and Warrants on the First Closing Date. The obligation hereunder of the Purchasers to purchase the Shares and Warrants on the First Closing Date and consummate the
transactions contemplated by this Agreement is subject to the satisfaction or waiver, at or before the First Closing, of each of the conditions set forth below. These conditions are for the Purchasers’ sole benefit and may be waived by the
Purchasers at any time in their sole discretion. 
  
 (a)
Accuracy of the Company’s Representations and Warranties. Each of the representations and warranties of the Company in this Agreement and in each of the other Transaction Documents shall be true and correct in all material respects as of
the First Closing Date, except for representations and warranties that speak as of a particular date, which shall be true and correct in all material respects as of such date. 
  
 (b) Performance by the Company. The Company shall have performed, satisfied and complied in all material respects
with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the First Closing Date. 
  
 (c) No Suspension, Etc. Trading in the Company’s Common Stock shall not have been suspended by the Commission
(except for any suspension of trading of limited duration agreed to by the Company, which suspension shall be terminated prior to the First Closing), and, at any time prior to the First Closing Date, trading in securities generally as reported by
Bloomberg Financial Markets (“Bloomberg”) shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by Bloomberg, or on the American Stock Exchange, nor shall
a banking moratorium have been declared either by the United States or California State authorities, nor shall there have occurred any national or international calamity or crisis of such magnitude in its effect on any financial market which, in
each case, in the reasonable judgment of the Purchasers, makes it impracticable or inadvisable to purchase the Shares and the Warrants being purchased on the First Closing Date. 
  

 20 

 (d) No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction
shall have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation of any of the transactions contemplated by this Agreement. 
  
 (e) No Proceedings or Litigation. No action, suit or proceeding before
any arbitrator or any governmental authority shall have been commenced, and no investigation by any governmental authority shall have been threatened, against the Company or any Subsidiary, or any of the officers, directors or affiliates of the
Company or any Subsidiary, unless by or at the behest of a Purchaser, seeking to restrain, prevent or change the transactions contemplated by this Agreement, or seeking damages in connection with such transactions. 
  
 (f) Opinion of Counsel, Etc. The Purchasers shall have received an
opinion of counsel to the Company, dated the First Closing Date, in the form of Exhibit C hereto, and such other certificates and documents as the Purchasers or their counsel shall reasonably require incident to the First Closing. 

 
 (g) Warrants and Shares. The Company shall have delivered to the
Purchasers the originally executed Warrants (in such denominations as each Purchaser may request) and shall have delivered certificates representing the Shares (in such denominations as each Purchaser may request) being acquired by the Purchasers at
the First Closing. 
  
 (h) Resolutions. The Board of
Directors of the Company shall have adopted resolutions consistent with Section 2.1(b) hereof in a form reasonably acceptable to the Purchasers (the “Resolutions”). 
  
 (i) Certificate of Designations. As of the First Closing Date, the Company shall have filed with the Delaware
Secretary of State the Certificate of Designations. 
  
 (j)
Reservation of Shares. As of the First Closing Date, the Company shall have reserved out of its authorized and unissued Preferred Stock, solely for the purpose of effecting the issuance of the Shares, a number of shares of Preferred Stock
equal to the aggregate number of the Shares. As of the First Closing Date, the Company shall have reserved out of its authorized and unissued Common Stock, solely for the purpose of effecting the conversion of the Shares and the exercise of the
Warrants, a number of shares of Common Stock equal to the number of Conversion Shares and the number of Warrant Shares issuable upon conversion of the Preferred Stock and the exercise of the Warrants, respectively, assuming all of the Warrants were
granted on the First Closing Date (after giving effect to the Warrants to be issued on the First Closing Date and the Second Closing Date and assuming the Warrants were fully exercisable on such date regardless of any limitation on the timing or
amount of such exercises). 
  
 (k) Secretary’s
Certificate. The Company shall have delivered to the Purchasers a secretary’s certificate, dated as of the First Closing Date, as to (i) the Resolutions, (ii) the Certificate, (iii) the Bylaws, each as in effect at the First Closing, and
(iv) the authority and incumbency of the officers of the Company executing the Transaction Documents and any other documents required to be executed or delivered in connection therewith. 
  

 21 

 (l) Officer’s Certificate. On the First Closing Date, the Company shall have delivered to the
Purchasers a certificate of an executive officer of the Company, dated as of the First Closing Date, confirming the compliance by the Company with the conditions precedent set forth in this Section 4.2 as of the First Closing Date. 
  
 (m) Fees and Expenses. As of the First Closing Date, all
Purchasers’ fees and expenses contractually required to be paid by the Company shall have been or authorized to be paid by the Company as of the First Closing Date. 
  
 (n) Registration Rights Agreement. The Company shall have entered into the Registration Rights Agreement. 

 
 (o) Material Adverse Effect. No Material Adverse Effect shall have
occurred since the date of this Agreement. 
  
 Section 4.3
Conditions Precedent to the Obligation of the Company to Close and to Sell the Shares and Warrants on the Second Closing Date. The obligation hereunder of the Company to close and issue and sell the Shares and the Warrants to the Purchasers
on the Second Closing Date is subject to the satisfaction or waiver, at or before the Second Closing, of the conditions set forth below. These conditions are for the Company’s sole benefit and may be waived by the Company at any time in its
sole discretion. 
  
 (a) Accuracy of the
Purchasers’ Representations and Warranties. The representations and warranties of each Purchaser shall be true and correct in all material respects as of the date when made and as of the Second Closing Date as though made at that time,
except for representations and warranties that are expressly made as of a particular date, which shall be true and correct in all material respects as of such date. 
  
 (b) Performance by the Purchasers. Each Purchaser shall have performed, satisfied and complied in all material
respects with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by such Purchaser at or prior to the Second Closing Date. 
  
 (c) No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been
enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation of any of the transactions contemplated by this Agreement. 
  
 (d) Delivery of Purchase Price. The Purchase Price for the Shares and
Warrants being purchased at the Second Closing shall have been delivered to the Company at the Second Closing. 
  
 Section 4.4 Conditions Precedent to the Obligations of the Purchasers to Close and to Purchase the Shares and Warrants on the Second Closing Date.
The obligation hereunder of the Purchasers to purchase the Shares and Warrants on the Second Closing Date and 

  

 22 

 
consummate the transactions contemplated by this Agreement is subject to the satisfaction or waiver, at or before the Second Closing, of each of the
conditions set forth below. These conditions are for the Purchasers’ sole benefit and may be waived by the Purchasers at any time in their sole discretion. 
  

(a) Accuracy of the Company’s Representations and Warranties. Each of the representations and warranties of the Company in this Agreement
and the Registration Rights Agreement shall be true and correct in all material respects as of the Second Closing Date. 
  
 (b) Performance by the Company. The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Second Closing Date. 
  
 (c) No Suspension, Etc. Trading in the Company’s Common Stock shall not have been suspended by the Commission (except for any suspension of
trading of limited duration agreed to by the Company, which suspension shall be terminated prior to the Second Closing), and, at any time prior to the Second Closing Date, trading in securities generally as reported by Bloomberg shall not have been
suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by Bloomberg, or on the American Stock Exchange, nor shall a banking moratorium have been declared either by the United States or
California State authorities, nor shall there have occurred any national or international calamity or crisis of such magnitude in its effect on any financial market which, in each case, in the reasonable judgment of the Purchasers, makes it
impracticable or inadvisable to purchase the Shares and the Warrants being purchased on the Second Closing Date. 
  
 (d) No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation of any of the transactions contemplated by this Agreement. 
  
 (e) No Proceedings or Litigation. No action, suit or proceeding before any arbitrator or any governmental authority
shall have been commenced, and no investigation by any governmental authority shall have been threatened, against the Company or any Subsidiary, or any of the officers, directors or affiliates of the Company or any Subsidiary, unless by or at the
behest of a Purchaser, seeking to restrain, prevent or change the transactions contemplated by this Agreement, or seeking damages in connection with such transactions. 
  
 (f) Warrants and Shares. The Company shall have delivered to the Purchasers the originally executed Warrants (in such
denominations as each Purchaser may request) and shall have delivered certificates representing the Shares (in such denominations as each Purchaser may request) being acquired by the Purchasers at the Second Closing. 
  
 (g) Resolutions. The Resolutions shall be in full force and effect as
of the Second Closing and shall not have been amended or modified unless such amendment or modification was approved by the Purchasers. 
  

 23 

 (h) Certificate of Designations. The Certificate of Designations shall be in full force and effect
as of the Second Closing under the laws of Delaware and shall not have been amended or modified unless such amendment or modification was approved by the Purchasers, and the Company shall not have adopted or filed any other document designating
terms, relative rights or preferences of the Preferred Stock. 
  
 (i) Officer’s Certificate. On the Second Closing Date, the Company shall have delivered to the Purchasers a certificate of an executive officer of the Company, dated as of the Second Closing Date, confirming the accuracy of the
Company’s representations, warranties and covenants as of the Second Closing Date and confirming the compliance by the Company with the conditions precedent set forth in this Section 4.4 as of the Second Closing Date. 
  
 (j) Fees and Expenses. As of the Second Closing Date, all fees and
expenses required to be paid by the Company shall have been or authorized to be paid by the Company as of the Second Closing Date. 
  
 ARTICLE V 
  
 Certificate Legend 
  
 Section 5.1 Legend. Each certificate representing the Securities shall be stamped or otherwise imprinted with a legend substantially in the following form (in addition to any legend required by applicable state
securities or “blue sky” laws), which legend shall not be considered an encumbrance for the purpose of Section 2.1(d): 
  
 THE SECURITIES REPRESENTED BY THIS CERTIFICATE (THE “SECURITIES”) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”) OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR PATH 1 NETWORK TECHNOLOGIES INC. SHALL HAVE
RECEIVED AN OPINION OF ITS COUNSEL THAT REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT AND UNDER THE PROVISIONS OF APPLICABLE STATE SECURITIES LAWS IS NOT REQUIRED. 
  
 The Company agrees to prepare to reissue certificates representing any of the Securities, without the legend set forth
above, in the hands of the transferee, if at such time, prior to making any transfer of any such Securities, such holder thereof shall give written notice to the Company describing the manner and terms of such transfer and removal as the Company may
reasonably request. Such proposed transfer will not be effected until: (a) the Company has notified such holder that either (i) in the opinion of Company counsel, the registration of such Securities is not required in connection with such proposed
transfer, or (ii) a registration statement under the Securities Act covering such proposed disposition has been filed by the Company with the Commission and has become effective under the Securities Act; and (b) the Company has notified such holder
that either (i) in the opinion of Company counsel, the registration or 

  

 24 

 
qualification under the securities or “blue sky” laws of any state is not required in connection with such proposed disposition, or (ii) compliance
with applicable state securities or “blue sky” laws has been effected. The Company will use its best efforts to respond to any such notice from a holder within five (5) days. In the case of any proposed transfer under this Section 5.1, the
Company will use reasonable efforts to comply with any such applicable state securities or “blue sky” laws, but shall in no event be required, in connection therewith, to qualify to do business in any state where it is not then qualified
or to take any action that would subject it to tax or to the general service of process in any state where it is not then subject. The restrictions on transfer contained in this Section 5.1 shall be in addition to, and not by way of limitation of,
any other restrictions on transfer contained in any other section of this Agreement. 
  
 ARTICLE VI 
  
 Termination 
  
 Section 6.1 Termination by
Mutual Consent. This Agreement may be terminated at any time prior to the First Closing Date by the mutual written consent of the Company and the Purchasers. 
  
 Section 6.2 Effect of Termination. In the event of termination by the Company or the Purchasers, written notice
thereof shall forthwith be given to the other party and the transactions contemplated by this Agreement shall be terminated without further action by any party. If this Agreement is terminated as provided in Section 6.1 herein, this Agreement shall
become void and of no further force and effect, except for Sections 8.1 and 8.2, and Article VII herein. Nothing in this Section 6.2 shall be deemed to release the Company or any Purchaser from any liability for any breach under this Agreement, or
to impair the rights of the Company or such Purchaser to compel specific performance by the other party of its obligations under this Agreement. 
  
 ARTICLE VII 
  
 Indemnification 
  
 Section 7.1 General Indemnity. The Company agrees to indemnify and hold harmless each Purchaser (and its respective directors, officers, employees, affiliates, agents, successors and assigns) from and against
any and all losses, liabilities, deficiencies, costs, damages and expenses (including, without limitation, reasonable attorneys’ fees, charges and disbursements) incurred by each Purchaser or any such Person as a result of any inaccuracy in or
breach of the representations, warranties or covenants made by the Company herein. The Purchasers severally but not jointly agree to indemnify and hold harmless the Company and its directors, officers, employees, affiliates, agents, successors and
assigns from and against any and all losses, liabilities, deficiencies, costs, damages and expenses (including, without limitation, reasonable attorneys’ fees, charges and disbursements) incurred by the Company as result of any inaccuracy in or
breach of the representations, warranties or covenants made by the Purchasers herein. 
  

 25 

 Section 7.2 Indemnification Procedure. Any party entitled to indemnification under this Article
VII (an “indemnified party”) will give written notice to the indemnifying party of any matters giving rise to a claim for indemnification; provided, that the failure of any party entitled to indemnification hereunder to give notice
as provided herein shall not relieve the indemnifying party of its obligations under this Article VII except to the extent that the indemnifying party is actually prejudiced by such failure to give notice. In case any action, proceeding or claim is
brought against an indemnified party in respect of which indemnification is sought hereunder, the indemnifying party shall be entitled to participate in and, unless in the reasonable judgment of the indemnified party a conflict of interest between
it and the indemnifying party may exist with respect to such action, proceeding or claim, to assume the defense thereof with counsel reasonably satisfactory to the indemnified party. In the event that the indemnifying party advises an indemnified
party that it will contest such a claim for indemnification hereunder, or fails, within thirty (30) days of receipt of any indemnification notice to notify, in writing, such Person of its election to defend, settle or compromise, at its sole cost
and expense, any action, proceeding or claim (or discontinues its defense at any time after it commences such defense), then the indemnified party may, at its option, defend, settle or otherwise compromise or pay such action or claim. In any event,
unless and until the indemnifying party elects in writing to assume and does so assume the defense of any such claim, proceeding or action, the indemnified party’s costs and expenses arising out of the defense, settlement or compromise of any
such action, claim or proceeding shall be losses subject to indemnification hereunder. The indemnified party shall cooperate fully with the indemnifying party in connection with any negotiation or defense of any such action or claim by the
indemnifying party and shall furnish to the indemnifying party all information reasonably available to the indemnified party which relates to such action or claim. The indemnifying party shall keep the indemnified party fully apprised at all times
as to the status of the defense or any settlement negotiations with respect thereto. If the indemnifying party elects to defend any such action or claim, then the indemnified party shall be entitled to participate in such defense with counsel of its
choice at its sole cost and expense. The indemnifying party shall not be liable for any settlement of any action, claim or proceeding effected without its prior written consent. Notwithstanding anything in this Article VII to the contrary, the
indemnifying party shall not, without the indemnified party’s prior written consent, settle or compromise any claim or consent to entry of any judgment in respect thereof which imposes any future obligation on the indemnified party or which
does not include, as an unconditional term thereof, the giving by the claimant or the plaintiff to the indemnified party of a release from all liability in respect of such claim. The indemnification required by this Article VII shall be made by
periodic payments of the amount thereof during the course of investigation or defense, as and when bills are received or expense, loss, damage or liability is incurred, so long as the indemnified party irrevocably agrees to refund such moneys if it
is ultimately determined by a court of competent jurisdiction that such party was not entitled to indemnification. The indemnity agreements contained herein shall be in addition to (a) any cause of action or similar rights of the indemnified party
against the indemnifying party or others, and (b) any liabilities the indemnifying party may be subject to pursuant to the law. 
  

 26 

 ARTICLE VIII 
  
 Miscellaneous 
  
 Section 8.1 Fees and Expenses. Each party shall pay the fees and expenses of its advisors, counsel, accountants and other experts, if any, and all
other expenses, incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement; provided, however, that the Company shall pay a flat $30,000 to Gryphon Master Fund, L.P.
(“Gryphon”), the lead Purchaser, to reimburse Gryphon for the fees and expenses (including attorneys’ fees and expenses) incurred by it in connection with its due diligence review of the Company and the preparation,
negotiation, execution, delivery and performance of this Agreement and the other Transaction Documents and the transactions contemplated thereunder, $10,000 of which has already been paid and is non-refundable, and the remaining $20,000 of which
shall be due and payable in cash at the First Closing (and only if the First Closing occurs). If the First Closing occurs, the Company hereby authorizes and directs Gryphon to deduct $20,000 from the Purchase Price to be paid by Gryphon at the First
Closing in payment and satisfaction of such $20,000 due and payable by the Company at the First Closing. 
  
 Section 8.2 Specific Enforcement; Consent to Jurisdiction. The Company and the Purchasers acknowledge and agree that irreparable damage would occur
in the event that any of the provisions of this Agreement or the other Transaction Documents were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to an
injunction or injunctions to prevent or cure breaches of the provisions of this Agreement or the other Transaction Documents and to enforce specifically the terms and provisions hereof or thereof, this being in addition to any other remedy to which
any of them may be entitled by law or equity. 
  
 (b) The Company
and each Purchaser (i) hereby irrevocably submit to the non-exclusive jurisdiction of the United States District Court sitting in the Northern District of Texas and the courts of the State of Texas located in Dallas, Texas, County for the purposes
of any suit, action or proceeding arising out of or relating to this Agreement or any of the other Transaction Documents or the transactions contemplated hereby or thereby, and (ii) hereby waive, and agree not to assert in any such suit, action or
proceeding, any claim that it is not personally subject to the jurisdiction of such court, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of the suit, action or proceeding is improper. The Company and each
Purchaser consent to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing in this Section 8.2 shall affect or limit any right to serve process in any other manner permitted by law. The Company and the Purchasers hereby agree that the prevailing party in any suit,
action or proceeding arising out of or relating to the Shares, the Warrants or any Transaction Document, shall be entitled to reimbursement for reasonable legal fees from the non-prevailing party. 
  
 Section 8.3 Entire Agreement; Amendment. This Agreement and the
Transaction Documents contain the entire understanding and agreement of the parties with respect to the matters covered hereby and, except as specifically set forth herein or in the other 

  

 27 

 
Transaction Documents, neither the Company nor any Purchaser make any representation, warranty, covenant or undertaking with respect to such matters, and
they supersede all prior understandings and agreements with respect to said subject matter, all of which are merged herein; provided, however, that any non-disclosure agreement is not so superseded. No provision of this Agreement may
be waived or amended other than by a written instrument signed by the Company and the holders of at least a majority in interest of the then-outstanding Shares, and no provision hereof may be waived other than by a written instrument signed by the
party against whom enforcement of any such amendment or waiver is sought. No such amendment shall be effective to the extent that it applies to less than all of the holders of the Shares then outstanding. No consideration shall be offered or paid to
any Person to amend or consent to a waiver or modification of any provision of any of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents or holders of Shares, as the case may
be. 
  
 Section 8.4 Notices. Any notice, demand, request,
waiver or other communication required or permitted to be given hereunder shall be in writing and shall be effective (a) upon hand delivery by telecopy or facsimile at the address or number designated below (if delivered on a Business Day during
normal business hours where such notice is to be received), or the first Business Day following such delivery (if delivered other than on a Business Day during normal business hours where such notice is to be received), or (b) on the second Business
Day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be: 
  

			
	If to the Company:	  	Path 1 Network Technologies Inc.
	 	  	6215 Ferris Square
	 	  	Suite 140
	 	  	San Diego, California 92121
	 	  	Attention: Mr. John R. Zavoli, President & CEO
	 	  	Telecopier: (858) 450-4203
		
	 with copies (which copies
 shall not
constitute notice
 to the Company) to:
	  	Heller Ehrman White & McAuliffe LLP
	 	  	4350 La Jolla Village Drive, 7th Floor
	 	  	San Diego, California 92122
	 	  	Attention: Hayden Trubitt, Esq.
	 	  	Telecopier: (858) 450-8499
		
	If to any Purchaser:	  	At the address of such Purchaser set forth on Exhibit A to this Agreement.

  
 Any party hereto may
from time to time change its address for notices by giving at least ten (10) days written notice of such changed address to the other party hereto. 
  
 Section 8.5 Waivers. No waiver by any party of any default with respect to any provision, condition or requirement of this Agreement shall be
deemed to be a continuing waiver 

  

 28 

 
in the future or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right
hereunder in any manner impair the exercise of any such right accruing to it thereafter. 
  
 Section 8.6 Headings. The article, section and subsection headings in this Agreement are for convenience only and shall not constitute a part of this Agreement for any other purpose and shall not be deemed to
limit or affect any of the provisions hereof. 
  
 Section 8.7
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns. After the First Closing, the assignment by a party to this Agreement of any rights hereunder shall not
affect the obligations of such party under this Agreement. After the Closing, the Purchasers, in compliance with all applicable securities laws, may assign the Shares, the Warrants and their rights under this Agreement and the other Transaction
Documents and any other rights hereto and thereto without the consent of the Company. 
  
 Section 8.8 No Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns and is not for the benefit of, nor may any
provision hereof be enforced by, any other Person (other than indemnified parties, as contemplated by Article VII). 
  
 Section 8.9 Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of Delaware, without
giving effect to the choice of law provisions. This Agreement shall not be interpreted or construed with any presumption against the party causing this Agreement to be drafted. 
  
 Section 8.10 Survival. The representations and warranties of the Company and the Purchasers contained in Sections
2.1(o) and 2.1(s) shall survive indefinitely and those contained in Article II, with the exception of Sections 2.1(o) and 2.1(s), shall survive the execution and delivery hereof and each Closing until the date 365 days from the Second Closing Date,
and the agreements and covenants set forth in Articles I, III, V, VII and VIII of this Agreement shall survive the execution and delivery hereof and each Closing hereunder. 
  
 Section 8.11 Counterparts. This Agreement may be executed in any number of counterparts, all of which taken together
shall constitute one and the same instrument and shall become effective when counterparts have been signed by each party and delivered (including by facsimile and/or by photocopy) to the other parties hereto, it being understood that all parties
need not sign the same counterpart. 
  
 Section 8.12
Severability. The provisions of this Agreement are severable and, in the event that any court of competent jurisdiction shall determine that any one or more of the provisions or part of the provisions contained in this Agreement shall, for
any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provision or part of a provision of this Agreement and this Agreement shall be reformed and
construed as if such invalid or illegal or unenforceable provision, or part of such provision, would be valid, legal and enforceable to the maximum extent possible. 
  

 29 

 Section 8.13 Further Assurances. From and after the date of this Agreement, upon the request of
the Purchasers or the Company, the Company and each Purchaser shall execute and deliver such instruments, documents and other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate fully the intent and
purposes of this Agreement and the other Transaction Documents. 
  
 Section 8.14 Independent Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser
shall be responsible in any way for the performance of the obligations of any other Purchaser under any Purchaser Transaction Document. Nothing contained herein or in any other Purchaser Transaction Document, and no action taken by any Purchaser
pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with
respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser confirms that it has independently participated in the negotiation of the transactions contemplated hereby with the advice of its own counsel
and advisors. Each Purchaser shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of any other Transaction Documents, and it shall not be necessary for any
other Purchaser to be joined as an additional party in any proceeding for such purpose. Each Purchaser (other than Gryphon and GSSF Master Fund, LP (“GSSF”)) hereby agrees and acknowledges that (a) Warren W. Garden, P.C. was
retained solely by Gryphon and GSSF in connection with their due diligence review of the Company and the preparation, negotiation, execution, delivery and performance of this Agreement and the other Transaction Documents and the transactions
contemplated thereunder, and in such capacity has provided legal services solely to Gryphon and GSSF, (b) Warren W. Garden, P.C. has not represented, nor will it represent, any Purchaser (other than Gryphon and GSSF) in connection with the
preparation, negotiation, execution, delivery and performance of this Agreement or the other Transaction Documents or the transactions contemplated thereunder, and (c) each Purchaser (other than Gryphon and GSSF) should, if it wishes counsel with
respect to the preparation, negotiation, execution, delivery and performance of this Agreement or the other Transaction Documents or the transactions contemplated thereunder, retain its own independent counsel with respect thereto. 
  
 [Remainder of page intentionally left blank. Signature pages to follow.]

  

 30 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective
authorized officers or agents as of the date first above written. 
  

			
	PATH 1 NETWORK TECHNOLOGIES INC.
		
	 By:
	 	 /s/ John R. Zavoli

	 Name:
	 	John R. Zavoli
	 Title:
	 	President & Chief Executive Officer

  
 [Signatures of
Purchasers to follow on next pages.] 
  

 31 

									
	PURCHASERS:
	
	GRYPHON MASTER FUND, L.P.
		
	By:	 	Gryphon Partners, L.P., its General Partner
			
	 	 	By:	 	Gryphon Management Partners, L.P., its General Partner
				
	 	 	 	 	By:	 	Gryphon Advisors, L.L.C., its General Partner
					
	 	 	 	 	 	 	By:	 	 /s/ E.B. Lyon, IV

	 	 	 	 	 	 	 	 	E.B. Lyon, IV, Authorized Agent
		
	 x        
	 	Check box and initial if the foregoing Purchaser wishes to waive the provisions of Section 3.11(a). EBL (initial here)
	  
  
 GSSF MASTER FUND, LP

		
	By:	 	Gryphon Special Situations Fund, LP, its General Partner
			
	 	 	By:	 	GSSF Management Partners, LP, its General Partner
				
	 	 	 	 	By:	 	GSSF, LLC, its General Partner
					
	 	 	 	 	 	 	By:	 	 /s/ E.B. Lyon, IV

	 	 	 	 	 	 	 	 	E.B. Lyon, IV, Authorized Agent
		
	 x        
	 	Check box and initial if the foregoing Purchaser wishes to waive the provisions of Section 3.11(a). EBL (initial here)

  

 32 

  

			
	
	    RAPTORFUND
		
	     By:
	  	John S. Ingalls, Trustee of the RAPTORFUND
		
	    By:	  	 /s/ John S. Ingalls

	     Name:
	  	 John S. Ingalls

	     Title:
	  	 Trustee

		
	     x
	  	Check box and initial if the foregoing Purchaser wishes to waive the provisions of Section 3.11(a).
		
	 	  	JSI (initial here)

  

  

			
	PACKER FAMILY REV. TRUST DTD 5/22/00
		
	By:	 	 /s/ Robert Packer

	 Name:
	 	 Robert Packer

	 Title:
	 	 Trustee

		
	  ̈
	 	Check box and initial if the foregoing Purchaser wishes to waive the provisions of Section 3.11(a).              (initial
here)

  

			
	 [Name of Purchaser]

		
	By:	 	 /s/ John R. Zavoli

	 Name:
	 	 John R. Zavoli

	 Title:
	 	 
		
	  ̈
	 	Check box and initial if the foregoing Purchaser wishes to waive the provisions of Section 3.11(a).              (initial
here)

  

			
	 [Name of Purchaser]

		
	By:	 	 /s/ Jeffrey Hale

	 Name:
	 	  Jeffrey Hale

	 Title:
	 	 VP of Sales, Path 1

		
	  ̈
	 	Check box and initial if the foregoing Purchaser wishes to waive the provisions of Section 3.11(a).              (initial
here)

  

			
	 [Name of Purchaser]

		
	By:	 	 /s/ Mark Rosenbloom

	 Name:
	 	 Mark Rosenbloom

	 Title:
	 	 
		
	  ̈
	 	Check box and initial if the foregoing Purchaser wishes to waive the provisions of Section 3.11(a).              (initial
here)

  

			
	 [Name of Purchaser]

		
	By:	 	 /s/ Steven R. Simpson

	 Name:
	 	 Steven R. Simpson

	 Title:
	 	 
		
	 x
	 	Check box and initial if the foregoing Purchaser wishes to waive the provisions of Section 3.11(a). SRS (initial here)

  

			
	 [Name of Purchaser]

		
	By:	 	 /s/ Christopher R. Cope

	 Name:
	 	   Christopher R. Cope, TTEE U/A DTD 11/22/89

	 Title:
	 	   Trustee

		
	x	 	 Check box and initial if the foregoing
 Purchaser
wishes to waive the provisions of
 Section 3.11(a). CRC (initial here)

  

			
	 [Name of Purchaser]

		
	By:	 	 /s/ Robert R. Bears, Sr.

	 Name:
	 	   Robert R. Bears, Sr.

	 Title:
	 	 
		
	 x
	 	Check box and initial if the foregoing Purchaser wishes to waive the provisions of Section 3.11(a). RRB (initial here)

  

			
	 [Name of Purchaser]

		
	By:	 	 /s/ Robert R. Bears, Jr.

	 Name:
	 	   Robert R. Bears, Jr.

	 Title:
	 	 
		
	 x
	 	Check box and initial if the foregoing Purchaser wishes to waive the provisions of Section 3.11(a). RRB (initial here)

  

			
	 [Name of Purchaser]

		
	By:	 	 /s/ Richard W. Cope

	 Name:
	 	   Richard W. Cope, Officer

	 Title:
	 	   Cope Enterprises L.P., a Partnership

		
	  ̈
	 	Check box and initial if the foregoing Purchaser wishes to waive the provisions of Section 3.11(a).              (initial
here)

  

			
	 [Name of Purchaser]

		
	By:	 	 /s/ Anthony M. Giallourakis

	 Name:
	 	    Anthony M. Giallourakis

	 Title:
	 	 
		
	  ̈
	 	Check box and initial if the foregoing Purchaser wishes to waive the provisions of Section 3.11(a).              (initial
here)

  

 EXHIBIT A 
  
 LIST OF PURCHASERS 
  

															
	 Names and Addresses
 of Purchasers

	  	 Dollar Amount of
Investment at
 First Closing

	  	Number of
Shares Purchased
at First Closing

	  	 Number of Warrants
Purchased at
 First Closing

	  	 Dollar Amount of
Investment at
 Second Closing

	  	Number of
Shares Purchased
at Second Closing

	  	 Number of Warrants
Purchased at
 Second Closing

	 Gryphon Master Fund, L.P.
 Attn: Ryan R. Wolters
	  	$	1,000,000	  	307,692	  	153,846	  	$	0	  	0	  	0
							
	 With a copy to:
	  	 	 	  	 	  	 	  	 	 	  	 	  	 
							
	 Warren W. Garden, P.C.
 Attn: Warren W. Garden, Esq.
	  	 	 	  	 	  	 	  	 	 	  	 	  	 
	 GSSF Master Fund, LP
 Attn: Timothy M. Stobaugh
	  	$	500,000	  	153,846	  	76,923	  	$	0	  	0	  	0
							
	 With a copy to:
	  	 	 	  	 	  	 	  	 	 	  	 	  	 
							
	 Warren W. Garden, P.C.
 Attn: Warren W. Garden, Esq.
	  	 	 	  	 	  	 	  	 	 	  	 	  	 
	 John R. Zavoli
	  	$	10,000	  	3,077	  	1,538	  	$	0	  	0	  	0
	 Jeff C. Hale
	  	$	10,000	  	3,077	  	1,538	  	$	0	  	0	  	0
	 Mark Rosenbloom
	  	$	150,000	  	46,154	  	23,077	  	$	0	  	0	  	0
	 Packer Family Rev. Trust dtd
 Attn: Robert Packer
	  	$	25,000	  	7,692	  	3,846	  	$	0	  	0	  	0
	 RAPTORFUND
 Attn: John S. Ingalls
	  	$	113,750	  	35,000	  	17,500	  	$	0	  	0	  	0
	 Steven R. Simpson
	  	$	0	  	0	  	0	  	$	200,000	  	61,538	  	30,769
	 Christopher R. Cope TTEE U/A
	  	$	0	  	0	  	0	  	$	100,000	  	30,769	  	15,385
	 Cope Enterprises LLP
 Attn: Richard W. Cope
	  	$	0	  	0	  	0	  	$	100,000	  	30,769	  	15,385
	 Robert R. Bears, Sr.
	  	$	0	  	0	  	0	  	$	200,000	  	61,538	  	30,769
	 Robert R. Bears, Jr.
	  	$	0	  	0	  	0	  	$	300,000	  	92,308	  	46,154
	 Anthony M. Giallourakis
	  	$	0	  	0	  	0	  	$	100,000	  	30,769	  	15,385
	 Totals
	  	$	1,808,750	  	556,538	  	278,268	  	$	1,000,000	  	307,691	  	153,847

  
  

 A-1 

 EXHIBIT B 
  
 FORM OF WARRANT 
  

 B-1 

 EXHIBIT C 
 FORM OF OPINION 
  
 1. The
Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware and has the requisite corporate power to own, lease and operate its properties and assets, and to carry on its business as
presently conducted. The Company is duly qualified as a foreign corporation to do business and is in good standing in the State of California. 
  
 2. The Company has the requisite corporate power and authority to enter into and perform its obligations under the Transaction Documents and to issue the
Securities. The execution, delivery and performance of each of the Transaction Documents by the Company and the consummation by it of the transactions contemplated thereby have been duly and validly authorized by all necessary corporate action. Each
of the Transaction Documents has been duly executed and delivered by the Company. No Securities are subject to any preemptive rights under the Certificate or the Bylaws. 
  
 3. The Shares and the Warrants have been duly authorized and, when delivered against payment in full as provided in the
Purchase Agreement, will be validly issued, fully paid and nonassessable. The Conversion Shares have been duly authorized and reserved for issuance, and, when delivered upon conversion of the Shares, will be validly issued, fully paid and
nonassessable. The Warrant Shares have been duly authorized and reserved for issuance, and, when delivered upon exercise as provided in the Warrants, will be validly issued, fully paid and nonassessable. 
  
 4. The execution and delivery of the Transaction Documents and the issuance
of the Securities do not (a) violate any provision of the Certificate or Bylaws, (b) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of
termination, amendment, acceleration or cancellation of, any material agreement, mortgage, deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which the Company is a party and which is listed as an exhibit to
any Company Form 10-K or Form 10-Q, (c) create or impose a lien, charge or encumbrance on any property of the Company under any agreement or any commitment listed as an exhibit to any Company Form 10-K or Form 10-Q, or (d) result in a violation of
any Federal or California state statute, rule, regulation, or, to our knowledge, order, judgment, injunction or decree (including Federal and California state securities laws and regulations) applicable to the Company or by which any property or
asset of the Company is bound or affected, except, in all cases other than violations pursuant to clauses (a) and (d) above, for such conflicts, default, terminations, amendments, acceleration, cancellations and violations as would not, individually
or in the aggregate, have a Material Adverse Effect. 
  
 5. No
consent, approval or authorization of or designation, declaration or filing with any Federal or California state governmental authority on the part of the Company is required under any Federal or California state law, rule or regulation in
connection with the valid execution and delivery of the Transaction Documents, or the offer, sale or issuance of the Securities by the Company to you, other than (a) filings as may be required by applicable Federal 

  

 C-1 

 
and California state securities laws and regulations and The American Stock Exchange rules and regulations, and (b) the filing of the Certificate of
Designations with the Delaware Secretary of State. 
  
 6. To our
knowledge, there is no action, suit, claim, investigation or proceeding pending or threatened against the Company which questions the validity of the Agreement or the transactions contemplated thereby or any action taken or to be taken pursuant
thereto. There is no action, suit, claim, investigation or proceeding pending, or to our knowledge, threatened, against or involving the Company or any of its properties or assets and which, if adversely determined, is reasonably likely to result in
a Material Adverse Effect. To our knowledge, there are no outstanding orders, judgments, injunctions, awards or decrees of any court, arbitrator or governmental or regulatory body against the Company or any officers or directors of the Company in
their capacities as such. 
  
 7. Based in part on your
representations and warranties made in the Purchase Agreement, the offer, issuance and sale of the Securities by the Company to you are exempt from the registration requirements of the Securities Act of 1933, as amended. 
  
 8. The Company is not, and as a result of and immediately upon Closing will
not be, an “investment company” or a company “controlled” by an “investment company,” within the meaning of the Investment Company Act of 1940, as amended. 
  

 C-2 

 EXHIBIT D 
  
 FORM OF CERTIFICATE OF DESIGNATIONS 
  

 D-1 

 EXHIBIT E 
  
 FORM OF REGISTRATION RIGHTS AGREEMENT 
  

 E-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}]]